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           Viruses are tiny intracellular parasites that often cause devastating diseases on cellular 
organisms. To suppress viral infection, cellular organisms have evolved a wide spectrum of 
antiviral defense mechanisms. Antiviral RNA interference (RNAi) is one of the antiviral 
mechanisms conserved in eukaryotes. During antiviral RNAi, the destruction of invading viral 
RNAs is mediated by small interfering RNAs derived from the viral replication complex, in the 
form of double-stranded RNA (dsRNA). Because of its sequence-specific nature, antiviral RNAi 
can also target host homologous transcripts, for instance leading to disease syndromes in plants. 
As a counter-defense mechanism, many viruses produce RNAi suppressors that suppress RNAi 
through distinct mechanisms. So far, RNAi-mediated virus-host interactions have remained 
largely unexplored in the nematode worms which are known to have a unique RNAi gene 
constitution. As a result, whether virus-derived siRNAs (viRNAs) are able to direct worm gene 
silencing, whether heterologous viral suppressors are still functional in nematode worms and 
how the worm-specific RNAi genes contribute to antiviral RNAi remain open questions.   
          In this thesis I describe my exploration of several aspects of RNAi-mediated virus-host 
interaction in the nematode Caenorhabditis elegans. Through the study of virus-induced gene 
silencing in C. elegans I found that viRNAs can target and silence host genes. This is the first 
demonstration that viRNAs have the potential to silence host gene expression in the animal 
kingdom. Since certain viral suppressors that inhibit viRNA function without a size reference 
become resistant to RNAi but some suppressors that specifically suppress the function of 21-
nucleotide (nt) viRNAs still sensitive to RNAi, I conclude that 21-nt viRNAs do not play a major 
role in worm antiviral RNAi. My study on the function of a worm-specific RNAi gene, called 
rsd-2 (RNAi spreading defective 2), suggested that antiviral RNAi in C. elegans can be initiated 
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in the absence of a dsRNA binding protein, which is in sharp contrast to that in plant and insect 
systems. Through functional domain swap and viRNA profiling, I found that RIG-I-like RNA 
helicases contribute to worm antiviral RNAi through distinct mechanisms with one of them 




CHAPTER 1 GENERAL INTRODUCTION 
1.1 Antiviral RNA interference 
           RNA interference (RNAi), or RNA silencing, is a phylogenetically conserved gene 
regulation mechanism mediated by several classes of small non-coding RNAs (1, 2). One of the 
major biological functions of RNAi is antiviral defense which serves as major innate antiviral 
mechanism in fungi, plants and invertebrates (3-14). Accumulating evidence suggests that RNAi 
directed viral immunity (RDVI) is initiated upon the processing of viral double-stranded RNAs 
(dsRNAs), formed through intramolecular base-pairing or during viral replication, into small 
interfering RNAs (siRNAs) by type III ribonuclease called Dicer. Apparently, Dicer processing 
of viral dsRNA on its own is not sufficient to curb viral infection, because efficient RDVI also 
requires other RNAi factors, such as Argonaute (AGO) proteins, RNA-dependent RNA 
polymerases (RdRPs), dsRNA binding proteins (DRBPs) and putative RNA helicases (Figure 1.1) 
(7, 15-20).  
siRNA mediated silencing of invading viruses culminates with the cleavage of viral 
transcripts by AGO proteins which recruit siRNAs as sequence guide for target RNA selection 
and slice the matching RNA molecules with their RNase H-like activity (20). In plants and the 
nematodes Caenorhabditis elegans, RNA-dependent RNA polymerases (RdRPs) contribute to 
RDVI by amplifying siRNAs (17, 21, 22) through generating secondary viral siRNAs. The plant 
RdRPs convert cleaved viral transcripts into dsRNAs which are further processed into secondary 
siRNAs, whereas the worm RdRPs initiate de novo synthesis of secondary siRNAs using the 
cleaved transcripts as template in a dicer-independent manner (16, 17, 21, 22). Double stranded 
binding proteins (DRBPs) are essential components of RDVI in plants, insects and nematode 
worms. Whereas some DRBPs play important role in Dicer processing of dsRNA into siRNAs 
some other DRBPs are found to facilitate the loading siRNA into AGO proteins (23-27). Putative 
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RNA helicases are implicated in various siRNA-mediated gene silencing pathways. However, 
how they contribute to antiviral RNAi remains largely unknown. 
Plant RDVI also involves an intercellular signal that is believed to restrict systemic 
spreading of the invading virus by priming an antiviral status prior to virus arrival (28, 29). 
Recently, siRNAs were found to serve as the physical carrier of this mobile silencing signal in 
plants (30, 31). In fruit fly RDVI also spreads systemically although the mechanism involved is 
different (32).  
 
Figure 1.1 Schematic pathway of RNAi-mediated antiviral silencing. Exogenous long double 
stranded RNA (dsRNA) is processed by Dicer into small interfering RNAs (siRNA) with 21-24 
nt and 3’end overhang, Argonaute proteins (AGO) recruit the passenger strand of siRNA and 
cleave the targets which are complimentary to siRNAs. RNA dependent RNA polymerase 
(RdRP) amplifies the RNAi by converting the cleavage products into secondary siRNA duplex. 
The image was adapted from review (33).  
1.2 Viral Suppression of RNAi 
Since RDVI is mediated by siRNAs processed from replicating viral genomes, the chance 
for the targeted viruses to evade RDVI through generating genome variants is low. As a 
counterdefense mechanism, many viruses encode diverse, in term of sequence and structure, 
classes of proteins capable of suppressing RNAi. Viral suppressors of RNAi (VSRs) can be 
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encoded by fungus, plant and animal viruses with DNA or RNA genomes. Accumulating 
evidence suggests that VSRs often target viral or host factors to suppress the biogenesis and/or 
function of siRNAs (34). For example, the B2 proteins produced by flock hosuse virus (FHV) or 
nodamura virus (NoV) have been shown to bind long dsRNAs, thereby suppressing the 
processing of dsRNAs into siRNAs by Dicer. Nonetheless, the p19 protein of tomato bushy stunt 
virus (TBSV) and the 2b protein of tomato aspermy virus (TAV) specifically bind and inhibit the 
function of 21-nucleotide (nt) siRNAs (9, 35-40). The fact that TBSV p19 is an active suppressor 
of RNAi in both insect and mammalian cells suggests that its function does not require host 
factors (41-43). In plants, VSRs are capable of interfering with the function of microRNAs 
(miRNAs), a class of endogenous small noncoding RNAs with important function in 
development and stress response (44-46). miRNAs are encoded by endogenous genes and their 
biogenesis requires Dicer proteins and cofactors. Accumulating evidence suggests that 
suppression of miRNA function by VSRs is responsible for the developmental defects induced 
by plant virus infection (47, 48).  
          Development of RDVI suppression assays has played an important role in the discovery 
and characterization of VSRs and the study of VSR-mediated virus-host interaction. In plants, 
the fastest and most popular way is through agrobacterium-mediated transient expression assay 
(Figure 1.2) (33). Usually, the candidate VSR was co-infiltrated with a reporter gene, such as 
green fluorescent protein (GFP) encoding gene, using agrobacterium infiltration to the plants, 
then the VSR can be identified if plants were resistant to the local silencing triggered and 
targeted by the reporter gene (49). Another strategy is to deliver the candidate VSR into the 
reporter plants through genetic cross, thus, the on-going silencing will be reversed (6). However, 
using those methods, it was difficult to test systemic silencing transported between cells through 
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this assay. Thus, a grafting assay was adopted to identify the suppression of systemic silencing 
by visualizing the silencing signal generated from the rootstock which can spread to scion and 
silence the transgene in the scion (29, 49). In the cell culture system, the strategy to identify 
VSRs was based on rescue of the mutant virus defective of replication. Briefly, a known virus 
genome was modified to obtain an un-translated suppressor, thus, viral replication would be 
suppressed in wild type animals, but would be restored if a suppressor is provided in trans or 
from heterologous virus (12). Therefore, a candidate viral protein is identified as VSR when its 
expression rescues the accumulation of a VSR-deficient mutant virus or replicon after replication 
in a host cell. 
 
Figure 1.2 Identification of VSR through co-agroinfiltration. The transgenic GFP Nicotiana 
benthamiana leaves were co-infiltrated with a mixture of two agrobacterium tumefaciens strains, 
one directs the expression of GFP and thereby induces GFP mRNA silencing, and the other 
simultaneously expresses the FHV-encoded B2 (left leaf), B1 (middle leaf), or the plant 
cucumoviral 2b (right leaf). The leaves were detached and photographed under UV illumination 
6 days after infiltration. GFP silencing is visualized in the middle leaf as a bright red color zone 
surrounding the infiltrated patch caused by chlorophyll fluorescence. The image was adapted 
from (7). 
         So far, little is known about viral suppression of RDVI in C. elegans. Recent studies have 
discovered a naturally occurring virus that infects and induces RDVI in C. elegans (50). 
However, it is unknown if the virus encodes VSR or VSR expression enhances virus infection in 
C. elegans. Previously, the B2 protein of FHV has been shown to be required for efficient viral 
5 
 
replication in wild type worms but not in worm mutants defective in RDVI (9), suggesting a 
function for FHV B2 in worm RDVI suppression. However, it remains unknown if ectopic 
expression of FHV B2 suppresses RNAi induced by synthetic dsRNA or worm RDVI induced by 
FHV or heterologous viruses. 
1.3 Virus induced gene silencing 
            Owing to its sequence-specific nature, RDVI in plants can be redirected to target host 
transcripts with matching sequences (51). For example, potato virus X (PVX) and tobacco rattle 
virus (TRV) with modified genomes have been found to be able to induce potent silencing of 
homologous genes upon establishing successful infection (52-55). Based on this observation, 
virus induced gene silencing (VIGS) has been adopted as a genetic tool for the dissecting of 
diverse biological pathways in plants (55, 56). Very recently, it has been shown that the same 
mechansim involved in VIGS is also responsible for the induction of viral diseases (57, 58). 
Currently, although animal virus encoded microRNAs (miRNAs), processed from viral 
transcripts with hairpin like secondary structures, have been shown to modulate host gene 
expression thereby to facilitate virus infection (59-61), it remains to be an open question whether 
viRNAs also have the potential to modulate host gene expression in the animal kingdom. The 
nematode worm C. elegans would be an animal model of particular interest to address this 
question, considering the fact that, like plants, C. elegans genome also encodes RdRP as 
important component  of RDVI (19, 62). 
1.4 Worm-specific antiviral RNAi genes 
         In addition to Dicer, AGO and RdRP proteins, the worm RDVI also requires some unique 
components, such as DRH-1 (Dicer related RNA helicase 1) and RSD-2 (RNAi spreading 
defective 2) (62). DRH-1 encodes a putative DExD/H box RNA helicase that shares significant 
sequence homology with RIG-I (retinoic acid-inducible gene I), a cytosolic virus sensor that 
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initiates interferon-mediated viral immunity upon virus detection in mammals (63). Intriguingly, 
although essential to RDVI, DRH-1 appears to be dispensable in RNAi triggered by artificial 
dsRNAs, suggesting a dedicated role of DRH-1 in antiviral defense (62). Previously, it was 
reported that viRNAs detected in drh-1 mutants became undetectable in drh-1;rde-4 double 
mutants (62), suggesting that DRH-1, together with RDE-1 and RRF-1, functions in the same 
genetic pathway as RDE-4.  
RSD-2 together with SID-1 (systemic RNA interference-deficient 1) was originally 
identified as one the key factors that enable systemic spreading of RNAi (1, 64, 65). A recent 
study suggested that RSD-2 contributes to the accumulation of secondary siRNAs in both 
exogenous and endogenous RNAi pathways (66). Since rsd-2 mutants displayed defects in 
transposon silencing under unfavorable condition it is believed that RSD-2 plays an important 
role in maintaining chromosome integrity (67). SID-1 contains multiple putative transmembrane 
domains and has been shown to be required for dsRNA intake (65, 68, 69). Interestingly, a recent 
study suggested that at least two classes of silencing dsRNA RNAs that move between C. 
elegans tissues can act as or generate the systemic silencing signal (70). Currently, whether SID-
1 contributes to systemic RNAi by transporting these two classes of silencing RNAs remains 
largely unknown. Previously, high concentration of dsRNAs were found to trigger efficient 
RNAi in the absence of RDE-4 (71), but the biological significance of this observation remains 
poorly understood.  
RSD-2 was implicated in RDVI in a genetic screen that selected for genes whose 
downregulation by dsRNA feeding led to loss of RDVI (62). Since rsd-2 acting as an RDVI 
genes is unique to nematode worms it would be interesting to ask whether worm-specific genes 
direct antiviral silencing in the absence of RDE-4.   
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1.5 RIG-I-like RNA helicases and RDVI 
Intriguingly, antiviral RNAi in C. elegans is also regulated by Dicer-related helicase 1 
(DRH-1), which is highly homologous to mammalian RIG-I (retinoic acid- inducible gene I) and 
is largely dispensable for exogenous RNAi (62). RIG-I is a key component of mammalian 
antiviral innate immunity (72-74). This finding thus suggests that RIG-I-like RNA helicases 
(RLHs) contribute to distinct antiviral mechanisms across kingdoms. Whereas antiviral RNAi 
induced by a Flock house virus (FHV)-based RNA replicon is dependent on drh-1, a reduced 
replication of the FHV replicon is detected in mutant nematodes defective in drh-2, suggesting 
that drh-2 is a negative regulator of RDVI in worms. The DRH family of genes in C. elegans is 
absent in insects and plants. Each of the DRH proteins contains homologous helicase domain and 
C-terminal regulatory domain (CTD) originally identified in RIG-I. A unique N-terminal domain 
is found in DRH-1 and DRH-3 but not in DRH-2 (62, 75). Currently, how DRH-1 contributes to 
antiviral silencing, through which mechanism DRH-2 negatively regulates antiviral silencing, 
and whether DRH-3, which shares similar domain structure with DRH-1, plays a role in antiviral 
silencing remains largely unknown.  
Previous studies showed that RIG-I functions as virus sensor in interferon mediated 
antiviral immunity in mammals (63, 72, 76-78). Pathogen sensing by RIG-I leads to the 
transcriptional activation of effector genes in the nucleus (72). In contrast, DRH-1 functions in 
RNAi-mediated antiviral immunity. Specifically, detection of viral double-stranded RNA 
(dsRNA) by Dicer endonucleases is associated with the production of small interfering RNAs 
(siRNAs), which subsequently direct sequence-specific antiviral immunity through RNA 
interference (RNAi) in cytoplasm (79-82). Currently, how DRH-1 contributes to RDVI remains 
largely unknown. As a result, whether RLHs confer similar biological function in distinct 




Figure 1.3 Schematic structure of RIG-I-like RNA Receptors family. CARD: caspase activation 
and recruitment domain; RD: regulatory domain. The image was adapted from review (83).  
          The homologous DExD/H box helicase domain of mammalian RIG-I is flanked by the N-
terminal caspase activation and recruitment domains (CARDs) and a C-terminal regulatory 
domain (CTD) (Figure 1.3). RIG-I binding of the viral 5’-triphosphate dsRNA through the 
helicase domain and CTD activates the downstream signaling events, leading to the induction of 
interferon-dependent antiviral immunity (84-86). The mammalian genomes also encode two 
additional RLHs, melanoma differentiation-associated gene 5 (MDA5) and laboratory of 
genetics and physiology 2 (LGP2). Both MDA5 and LGP2 contain CTD, but the N-terminal 
CARDs are found only in MDA5 (Figure 1.3). MDA5 senses viruses that are not detected by 
RIG-I via a distinct strategy whereas LGP2 seems to function as a regulator of RIG-I and MDA5 
activities through currently unknown mechanism (76, 87-90). The worm RLHs and mammalian 
RLHs share not only similar functional domain organization but also similar functionality 
(Figure 1.4) (62). Mechanistic study of worm RLHs is expected to have direct input to our 
understanding of mammalian virus sensing mediated by RLHs.    
1.6 C. elegans and RDVI 
C. elegans has recently emerged as an attractive model organism to study RDVI. Since 
RNAi triggered by artificial dsRNA mechanistically recapitulates RDVI, previous studies on 




Figure 1.4 Structure of RIG-I like RNA helicases (RLH) and homologues. CARDS: Caspase 
Activation and Recruitment Domains. DexD/H: the DEAD-box domain of RNA helicase 
superfamily. CTD: C-terminal regulatory domains. DRH: Dicer-related Helicase. The image was 
adapted from review (91). 
RDVI in C. elegans nematodes. Current models envision that, as shown in Figure 1.5, the worm 
RDVI is initiated upon the processing of viral dsRNA into primary viRNAs by the worm Dicer 
called DCR-1 (19, 62, 92). DCR-1 also processes precursor microRNAs (miRNAs) into mature 
miRNAs, a class of endogenous small RNAs with important role in development (93). Whereas 
efficient processing of viral dsRNA into primary viRNA requires a dsRNA binding protein 
termed RDE-4 (RNAi defective 4), the processing of precursor miRNAs into mature miRNAs 
appears to be RDE-4 independent (8, 62, 75, 93, 94). Interestingly, RDE-4 as a key factor of 
RDVI is also conserved in the fruit fly whose genome is known to encode two Dicer proteins 
with dedicated function in the biogenesis of siRNA and miRNA respectively (75, 94-97). So far, 
at least two closely related AGO proteins, RDE-1 (RNAi defective 1) and C04F12.1, have been 
found to play important role in RDVI in C. elegans (8, 9, 19, 62). RDE-1 is one of the 27 worm 
Argonauts that has the “slicer” activity, an RNase H like activity that cleaves the RNA molecule 
with perfect sequence match to the guide strand of siRNAs (98, 99). Interestingly, the “slicer” 
activity of RDE-1 is only required for the cleavage of the passage-strands of primary viRNAs but 
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not the cleavage target (100). However, the binding of target by the guide strand of primary 
siRNAs, together with RDE-1,  is believed to trigger the RdRP activity of RRF-1 which initiates 
the de novo synthesis of secondary siRNAs using the target viral RNAs as templates. Unlike 
primary siRNAs, all secondary siRNAs are singled-stranded and are known to carry a tri- 
phosphate group at the 5’ end (5’ ppp) (101, 102). These secondary siRNAs are believed to bind 
secondary AGO proteins that destroy target viral RNAs through currently unknown mechanisms 
(103). The fact that RDE-1 is required for production of secondary siRNAs suggests that RRF-1 
functions downstream of RDE-1 in the same genetic pathway  (104) (103).  Currently, how 
C04F12.1 and secondary AGO proteins contribute to RDVI remains largely unknown.  
1.7 Objectives of my study 
The aim of my study is to better understand how RNAi regulates virus-nematode 
interactions using C. elegans as a model system. The C. elegans genome encodes RdRPs like the 
plant genomes. It also encodes single Dicer as mammals do. Thus, findings from my study are 
expected to have direct input to the study of RDVI in diverse organisms. My study on the 
function and mechanism of worm-specific genes is also expected to unravel some unique 
features of worm RDVI.  
To study virus-nematode host interaction mediated by VSRs, I developed a robust RDVI 
suppression assay using FHV B2 as a reference VSR. This assay has allowed for the 
identification of VSRs with RDVI suppression activity in C. elegans. Using this assay I not only 
demonstrated that the Orsay virus RNA2 encodes no RDVI suppression activity but also 
identified NoV B2 as a VSR that retained the RDVI suppression activity in worm. It was also 
clear from my study that FHV B2 mainly inhibits the function, rather than the biogenesis, of 
virus-derived primary siRNAs in C. elegans but is unable to suppress the function of worm 
miRNAs which use the same Dicer for biogenesis. Intriguingly, I found that TBSV p19 is not an 
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active RDVI suppressor in C. elegans. Since TBSV p19 is known to specifically bind and inhibit 
the function of 21 nt siRNAs, my observations suggested 21-nt primary siRNAs do not make 
major contribution to worm RDVI. 
  
Figure 1.5 Current working model for RNAi-mediated antiviral immunity in the nematode worm 
C. elegans. DCR-1: Dicer-1. RDE-1: RNAi deficient 1, an Agonaute protein. RDE-4: RNAi 
deficient 4, a double-stranded RNA binding protein. The passenger strands of primary siRNAs 
are in green whereas the guide strands are in red.  
By analyzing viral replication and viRNA accumulation in single and double worm 
mutants defective in rsd-2, I found that RSD-2, as an important component of worm RDVI, 
functions downstream of primary viRNA biogenesis. Most importantly, with an increase in viral 
replication, primary viRNAs accumulated to a higher level in rsd-2;rde-4 double mutants 
compared to that in rsd-2 single mutants,  suggesting an rde-4-independent mechanism for the 
biogenesis of primary viRNAs in C. elegans. I further showed that RRF-1, together with RDE-1, 
also contribute to the rde-4-indepedent RDVI. Notably, although playing an essential role in 
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facilitating the spreading of RNAi triggered by artificial dsRNAs, SID-1 appears dispensable in 
RDVI targeting a natural viral pathogen of C. elegans.  
To find out whether replicating virus can induce silencing of host genes in nematodes, I 
tested the silencing of cellular transcripts triggered by replicating virus in C. elegans. The results 
suggested that viRNAs derived from a modified flock house virus (FHV) can mediate potent 
silencing of cellular transcripts in a sequence-specific manner. Importantly, VIGS in C. elegans 
is inheritable, suggesting that profound epigenetic consequences in the progeny populations can 
be induced by invading viruses. Therefore, my study not only confirmed that viRNAs can 
modulate host gene expression in animal kingdom but also paved the way for in-depth study of 
novel virus-animal host interactions mediated by viRNAs. 
RLHs are unique antiviral RNAi gene as they are only found in nematode worms but not 
in fungi, plants or insects. The C. elegans genome encodes altogether 3 RLHs. Currently, how 
they contribute to worm RDVI remains largely unclear. In this study I showed that drh-1 and 
drh-3 of C. elegans are essential for antiviral RNAi, but exhibit distinct antiviral activities. Using 
a transgenic approach developed to assay for the antiviral function of drh-1 in whole animals, I 
examined the antiviral activity of the predicted domains in DRH-1 and determined if C. elegans 
antiviral RNAi could be mediated by any of the conserved domains of human RIG-I protein. My 
results indicate that C. elegans antiviral RNAi requires an essential activity of DRH-1 to detect 
viral dsRNA in a manner analogous to virus dsRNA sensing by RIG-I in mammals. Using the 
same strategy I found that the putative DRH-2 domains can functionally replace the 
corresponding domains of DRH-1 in antiviral silencing, suggesting that DRH-2 may act as a 




CHAPTER 2 MATERIALS AND METHODS 
2.1 Maintenance of C. elegans strains  
The Bristol isolate of C. elegans N2 was used as the reference wild-type strain 
throughout this study. All C. elegans strains except some temperature sensitive mutants are 
maintained at room temperature on Nematode Growth Medium (NGM) in petri dishes with a 
diameter of 35mm, 60mm or 100mm. A Wheaton dispenser, unispense, was used to prepare all 
of those dishes. The E. coli food lawn was produced by applying E. coli OP50 liquid culture to 
those dishes under sterile condition. Approximately 100 L4 larvae were transferred to new plates 
for maintenance of fresh worm stock every other day. 
2.2 Worm genetics 
All alleles used in this study are derived from N2 and include drh-1 (tm1329 and ok3495), 
drh-2 (ok951), drh-3 (ne4253), rsd-2 (tm1429 and pk3307), rde-1 (ne300), rde-4 (ne337), rrf-1 
(pk1417) and sid-1 (qt2). The genotypes of pk3307, sid-1, rde-1 and rde-4 worms were 
confirmed using skn-1 feeding RNAi and genomic DNA sequencing. The drh-3 mutant allele 
was confirmed through genomic DNA sequencing, combined with 25°C sterile phenotype. The 
genotypes of rrf-1, drh-1, drh-2, rsd-2 were confirmed by PCR using primer sets shown in Table 
1 (62). All worm strains are maintained in the room temperature, except drh-3, which is stored in 
19°C incubator. 
2.3 Genetic crosses 
Males are generated through heat shock (37°C for 45min). All genetic crosses were 
carried out on empty NGM petri dish with 100mM Ampicillin using one virgin hermaphrodite 
with 4-6 males for cross. Heterozygous F1s were singled out when the cross is successful. 




Table 2.1 PCR primer sets for mutant alleles amplification 






















2.4 C. elegans chromosomal integration 
40 young adult worms carrying extrachromosomal transgene arrays are treated with 3,500 
rad of gamma-ray from a 137Cs source. Eggs are collected upon 4 hours after induction, then 
approximately 500 F1s are picked up for screening integrated animals in the F3 generation. Once 
an integrant is confirmed, the worms will be back-crossed 4 times to reduce the non-specific 
genetic mutations. 
2.5 Plasmid constructs  
FR1gfp replicon was a derivative of pFR1-3 by replacing the NcoI-SacI fragment of FHV 
RNA1 with the full length GFP coding sequence as described in (62). This created a translational 
fusion of GFP with the N-terminal 23 amino acids of B2 and deletion of approximately 200 
nucleotides from the B2 open reading frame (ORF). HDV ribozyme sequences were added in the 
3’end of the viral genome so that all non-viral sequences at the 3’ end of FR1gfp transcripts will 
be removed after transcription. 
The FR1fp replicon construct was modified from FR1gfp, by replacing the full-length gfp 
coding sequence with its half 3’ end.  The start codon for the B2 protein was disrupted so that no 
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translation will be initiated from the B2 ORF. The FR1fpfs was created by digestion of the FR1fp 
construct with BamHI, followed by T4 polymerase end-filling and re-ligation.  
The DI634 replicon construct was created using the same strategy as that used for the 
development of FR1gfp. To facilitate the insertion of foreign sequences, a multiple cloning site 
(MCS) corresponding to AscI-XhoI-NotI was introduced into the 3’ end of DI634 at the position 
where the original viral sequence has been removed. The DI634unc22 construct was created by 
inserting a 552 nt sequence derived from the exon 7 of unc-22 into DI634 utilizing the AscI and 
NotI sites. Similarly, the DI634skn-1 construct was created by inserting 380 bp skn-1 coding 
sequence into the MCS of DI634.  
All constructs used for RNAi suppression activity assay were developed utilizing either a 
heat inducible promoter or a sur-5 promoter. To express RNAi suppressors using the heat 
inducible promoter, the candidate RNAi suppressor coding sequences were inserted into 
pPD49.83 utilizing the XmaI and Sac I sites. To express RNAi suppressors using the sur-5 
promoter the candidate RNAi suppressor coding sequences were inserted into LR50 described in 
(105). The coding sequences for TBSV p19 and TAV 2b were PCR amplified from 
corresponding T-DNA expression binary constructs described previously (49, 106). The point 
mutations in p19m and 2bm were introduced through PCR amplification of wild type genes 
using primers containing desired mutations. All resulting constructs were confirmed through 
DNA sequencing.  
In RSD-2 function rescue assay the Psur5::RSD-2 construct was developed by inserting 
wild type RSD-2 coding sequence, amplified through PCR, into the LR50 vector described in 
(105). The RSD-2 coding sequence in the resulting construct was confirmed by DNA sequencing.  
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The plasmid construct used to drive gfp dsRNA expression in E. coli was described in 
(105). Full length of eGFP coding sequence was amplified through PCR, and inserted into the 
L4440 vector through XbaI and SacI sites. The plasmid was first confirmed with genomic 
sequencing and then transformed into HT115 competent cells. Feeding RNAi targeting skn-1 
construct was built through the same strategy. 
2.6 Transgenic worms  
Transgenic animals were generated through gonadal microinjection of the target 
constructs. Briefly, the target plasmid constructs, each at a final concentration of 10 ng/µl, were 
mixed with the 2-log DNA ladder (New England Biolabs Inc.) at final concentration of 100 ng/µl 
and the reporter plasmid Pmyo-2::mCherry or PRF4 at final concentration 40 ng/µl and injected 
into the gonads of young adult worms. Normally 30-40 F0s were injected, extrachromosomal 
array were randomly passed down from F1 to progenies. Worms carrying reporter genes were 
maintained for chromosomal integration or function assay. 
2.7 RNAi experiments 
The skn-1 or gfp feeding RNAi assay was performed using a bacterial feeding protocol 
(107). Briefly, NGM agar plates containing 5 mM IPTG and 100 mg/ml carbenicillin were 
seeded with E. coli. HT115 strain expressing skn-1 or gfp dsRNAs. The skn-1 feeding RNAi was 
scored from the next generation of worms, while the gfp feeding RNAi result was determined 
after 48 hours induction. All RNAi experiments are carried at room temperature.  
2.8 Infectious filtrate preparation and Orsay virus inoculation 
Orsay virus was maintained using the JU1580 isolate at room temperature following 
protocol described previously (50). To prepare Orsay virus inoculums, infected JU1580 worms 
were washed off from slightly starved 10 cm plates using M9 buffer, 5ml per plate. The virus-
17 
 
containing liquid was then filtered through 0.22 µm filter unit (Millipore) and used to resuspend 
pelleted OP50 E. coli for NGM plate seeding. 
2.9 RNA preparation and Northern blot analysis 
To extract total RNA, 4-6 medium plates of adult worms were washed with ddH2O to 
14ml Falcon tubes, after removing supernatant, 5 volume of TRI reagent (Sigma aldrich, Inc.) 
was added and followed by homogenization. 1/5 volume of chloroform was added and the 
sample was spun with maximum speed for 10min at 4°C. Then, add equal volume of isopropanol 
was added to the supernatant to precipitate total RNA. To collect total RNA, the content was 
spun at 5000rpm for 5min. The pellet was then washed the with 70% Ethanol and resuspended in 
DEPC H2O. 
To detect high molecular weight RNA, including the viral genomic and subgenomic 
RNAs and the cellular transcripts, 4 to 6 µg total RNA of each sample was denatured, loaded in 
the 1.2% agarose gel, which was then transfer to the Hybond N+ membrane (GE Healthcare Inc.) 
followed by UV crosslinking using 1.8X105 µJ/CM2 as the output power (SpectroLinker). Then 
the membranes were hybridized with alkaline phosphatase-labeled cDNA probes derived from 
the target RNAs at 65C overnight (AlkPhos Direct Labeling module, GE Healthcare). After 
washing twice at 65C, then another twice at room temperature, the target RNAs were then be 
detected using CDP-Star Detection Reagent following the manufacture’s instruction (GE 
Healthcare). The probes for FR1gfp transcript detection were prepared using cDNA fragments 
amplified from the gfp coding sequence. The probes used to detect Orsay virus RNA1 were 




To prepare small RNA samples for Northern blot analysis, total RNAs were extracted 
from 10 large plates of worms following the procedure described above. Small RNAs were then 
enriched using the mirVana kit (Ambion). For small RNA detection, 10 to 20 µg of samples 
containing enriched small RNAs was resolved in 15% acrylamide denaturing gel (PAGE). After 
electrophoreses, all RNA samples were transferred into Hybond Nylon membranes followed by 
crosslinking.         
The detection of small RNAs, viRNAs or miRNAs, adopted  a miRNA detection protocol 
with minor modifications (108). Briefly, following the UV crosslinking, the membranes were 
hybridized with DIG-labeled DNA oligo probes in PerfectHyb buffer (Sigma Aldrich) overnight 
at 37C. The DNA oligos that would detect all minus-stranded viRNAs derived from the gfp 
region of FR1gfp were labeled using the DIG Oligonucleotide Tailing Kit (Roche Applied 
Science). The blots were then washed 3 times at 42C using the DIG Wash and Block Buffer Set 
(Roche Applied Science). The small RNAs were then detected using Alkaline Phosphatase 
linked Anti-Digoxigenin antibody together with the CSPD substrate (Roche Applied Science). 
For FR1fp siRNA detection, the probes were prepared using 32 DNA oligos covering the entire 
FP region of FR1fp. miR-58 detection was reprobed with the same membrane with DNA oligos 
ATTGCCGTACTGAACGATCTCA. The 4 DNA oligos that served as size references for 
viRNAs and miRNAs were detected using 4 DIG-labeled 4 DNA oligos with complementary 
sequences.  
2.10 Protein extraction and western blot analysis 
Total proteins were extracted from 5 medium plates of worms using lysis buffer (Boston 
Bioproduct, Inc.) with protease inhibitor cocktail (Thermo Scientific™). The mixture was 
homogenized for 1min, followed by centrifuge at maximum speed at 4C for 15min. The 
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supernatant was the collected and heat denatured. 20-30µg protein sample was resolved into 8% 
SDS-PAGE gel. After being transferred to Hybond-P PVDF membrane (GE Healthcare Life 
Science), the target proteins were detected with anti-HA as primary antibody (Cell Signaling 
Technology) and goat anti-rabbit secondary antibody (Cell Signaling Technology). As equal 
loading control, the same set of membranes was re-blotted using HRP linked anti-β-actin 
antibody (Cell Signaling Technology). 
2.11 Small RNA sequencing 
RNA extracts containing enriched small RNAs were used for the construction of small 
RNA libraries. To capture virus-derived secondary siRNAs, all input RNA samples were treated 
with tobacco acid pyrophosphatase (Epicentre) before being used for small RNA library 
construction. All small RNA libraries were generated using TruSeq RNA Sample Preparation Kit 
(Illumina) following the manufacture’s instruction and sequenced using the Illumina HiSeq2000. 
After the adaptor being removed, the small RNA sequences were analyzed with in-house 
pipelines described previously (109).  
2.12 DRH-1 and RSD-2 function rescue assay 
The DRH-1/RSD-2 function rescue assay utilized ectopic expression of DRH-1/RSD-2 
coding sequence in drh-1 (tm1329) / rsd-2 (tm1429) null mutants carrying a nuclear transgene 
corresponding to the FR1gfp replicon. The sur-5 promoter, known to be active in most of the 
worm somatic tissues (110), was used to drive the expression of DRH-1/RSD-2. A construct that 
directs mCherry expression in the pharynx tissue was used to produce a visible mark for the 
Psur5::RSD-2 transgene. The function rescue assay began with microinjection of target construct 
into the gonad of mutant worms together with the mCherry reporter construct. Because of the 
nature of worm transformation through gonad injection, most of the transgenic 
extrachromosomal arrays are randomly passed onto the next generations. As a result, some 
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progenies are free of the extrachromosomal arrays and thus can serve as internal negative control. 
Upon heat induction, which will initiate the replication of FR1gfp replicon, transgenic worms 
marked with red fluorescence in the pharynx will show no or decreased green fluorescence if the 
target transgene is able to restore the function of its derived mutants.  
2.13 Assay for miRNA biogenesis/function suppression activity 
Worms used in this assay contain a let-7 function reporter transgene, which contains GFP 
coding sequence fused with let-7 target sequence, namely the 3’ end untranslated region of lin-41, 
and a transgene expressing the let-7 miRNAs. Both transgenes are driven by the myo-2 promoter 
thus enhanced green fluorescence can be observed in the pharynx tissue in worms defective in 
miRNA biogenesis and/or function (111). The assay began with microinjection of plasmid 
constructs containing candidate VSR coding sequence driven by the myo-2 promoter into the 
reporter worm strain SX333 (obtained from the Caenorhabditis Genetics Center (CGC)). The 
PRF4 construct was co-injected to produce the roller phenotype as visual mark for the VSR 
transgene. Following microinjection, transgenic lines carrying transmittable extrachromosomal 
arrays were picked up and maintained at room temperature. For each transgenic line, the green 
fluorescence in the pharynx tissue was compared, at different developmental stages, in between 
worms that carry the extrachromosomal array and worms that do not. 
2.14 Terminator treatment of small RNA samples 
The terminator treatment was carried out by mixing 20 µg small RNA sample with 4 
units of Terminator exonuclease (Epicentre Inc.) in 50 µl reaction mix containing 1x buffer and 1 
unit of RNase inhibitor. The reaction mix was then incubated at 30C for 60 minutes. For both 
treatments, the treated small RNA samples were cleaned through extracting with phenol-




2.15 Imaging microscopy 
The green and red fluorescence images were recorded using the same exposure for each 
set of images. A Nikon digital camera p7000 mounted on a Nikon SMZ1500 microscope was 




CHAPTER 3 CHARACTERIZATION OF VIRUS-ENCODED RNAI 
SUPPRESSORS IN CAENORHABDITIS ELEGANS1 
3.1 Introduction 
           In fungi, plants and insects, antiviral RNAi mediated by virus-derived small interfering 
RNAs (siRNAs) represents a major antiviral defense mechanism that invading viruses have to 
overcome in order to establish infection. As a counterdefense mechanism, viruses of these hosts 
produce diverse classes of proteins, termed viral suppressors of RNAi (VSR) that suppress the 
biogenesis and/or function of viral siRNAs. So far, more than 30 VSRs have been identified 
(112). Accumulating evidence suggests that these VSRs suppress RNAi through distinct 
mechanisms. For instance, the B2 proteins of Flock house virus (FHV) binds dsRNAs without 
size references and suppress RNAi in both plants and insect kingdoms. It can be further inferred 
from these findings that B2 suppresses RNAi without the aid of host factors. Interestingly, the 
p19 protein of tomato bushy stunt virus (TBSV) was found to specifically bind 21-nucleotides 
siRNAs thereby to suppress their function. Further, certain viral suppressors can suppress the 
function of miRNAs, leading to plant diseases. RNAi-directed viral immunity (RDVI) is also 
conserved in the nematode Caenorhabditis elegans (C. elegans) which is known to possess some 
unique features, in term of RNAi gene constitution (9). Previous study suggested that in C. 
elegans the B2 protein of FHV is required for efficient viral replication but becomes dispensable 
in the RNAi defective mutant worms, such as rde-1, suggesting a function of B2 in RNAi 
suppression (9). Currently, whether HV B2 is able to suppress RNAi when produced in trans and 
how FHV B2 suppresses worm RNAi through a similar mechanism remain largely unknown. 
Moreover, Orsay virus, the very first natural viral pathogen of C. elegans, is known to replicate 
                                                 
1 “Part of this chapter previously appeared as [Guo X and Lu R, Characterization of Virus-
Encoded RNA Interference Suppressors in Caenorhabditis elegans, March 2013]. It is reprinted 
by permission of [Copyright © American Society for Microbiology—see appendix]” 
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at an enhanced level in RNAi defective mutants, suggesting a deficiency of Orsay virus in RNAi 
suppression. It is thus interesting to find out whether wild type Orsay virus contains functional 
suppressors. In this chapter, I developed an assay, based on rescue of a suppressor free FHV 
replicon, to identify viral suppressors of RNAi using FHV B2 as a reference VSR and 
characterized the function and mechanism of several VSRs identified in heterologous systems. 
Findings from this research not only identified the mode of action of FHV B2 in RNAi 
suppression but also revealed some unique features of worm antiviral RNAi. 
3.2 FHV B2 suppresses dsRNA triggered RNAi and RDVI targeting a natural viral 
pathogen of C. elegans.  
So far, no VSR has been shown to suppress classical RNAi triggered by long dsRNA in 
C. elegans. FHV B2 retains its RNAi suppression activity when produced in trans in both plant 
and insect system (7, 12, 38). Despite its insect origin, FHV B2 was shown to be required for 
efficient replication of the cognate virus in the wild type C. elegans but became dispensable in 
worm mutants defective in RDVI (9), suggesting that FHV B2 retains its RDVI suppression 
activity in worms. To find out whether FHV B2 suppresses classical RNAi in C. elegans we 
assayed the silencing of a gfp transgene triggered by ingestion of gfp dsRNA in worms carrying 
constitutively active nuclear transgene corresponding to FHV B1 and FHV B2 (Figure 3.1 panel 
A). The B1 protein of FHV, which is translated from the same subgenomic RNA as B2, is known 
to be inactive in RNAi suppression (7) and thus served as a control to FHV B2 in our test. As 
shown in Figure 3.1 panel B, silencing of the gfp transgene was suppressed in transgenic worms 
expressing FHV B2 but not in wild type N2 worms or worms expressing FHV B1, confirming 
that FHV B2 indeed suppresses long dsRNA triggered RNAi in worms. 
 Orsay virus is a naturally occurring viral pathogen of C. elegans that was originally 
isolated from a worm mutant defective in RDVI (50). Interestingly, the replication of Orsay virus 
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in wild type N2 worms is significantly weaker compared to that in RDVI-defective mutants. The 
fact that Orsay virus is still sensitive to RDVI suggested that its replication would be further 
enhanced in worms expressing a functional VSR. To test this hypothesis, we checked Orsay 
virus infection in transgenic worms constitutively expressing FHV B2. As shown in Figure 3.1 
panel C, compared to that in non-transgenic N2 worms and N2 worms expressing FHV B1, the 
replication of Orsay virus was significantly enhanced in transgenic N2 worms expressing FHV 
B2. These results together suggested that FHV B2 is able to suppress both long dsRNA triggered 
RNAi and RNAi triggered by natural viral infection in C. elegans. 
  
Figure 3.1 FHV B2 suppresses long dsRNA triggered RNAi and RDVI targeting Orsay virus. A. 
Schematic structure of the sur-5 promoter based transgenes. Psur-5, the promoter for worm gene 
sur-5. UTR, the 3’ end untranslated sequence of the worm gene unc-54. fB1, the B1 coding 
sequence of FHV. fB2, the B2 coding sequence of FHV. GFP, the coding sequence of green 
fluorescent protein. B. FHV B2 suppresses dsRNA triggered RNAi. All worms used in this test 
contain a nuclear transgene corresponding to Psur-5::GFP. Shown here is the accumulation of 
gfp transcripts in wild type N2 worms or worms containing Psur-5::fB1 or Psur-5::fB2 transgene 
as indicated. Asterisks denote total RNA samples extracted from worms fed on E. coli food 
expressing GFP dsRNA. Methylene blue-stained ribosomal RNA serves as equal loading control. 
C. FHV B2 enhances the replication of Orsay virus. Shown here is the accumulation of Orsay 
virus RNA1 in C. elegans isolate JU1580, wild type N2 worms, rde-1 mutants and worms 
expressing FHV B1 and B2 respectively. Total RNA was prepared 72 hours after virus 
inoculation. A 1.2kb cDNA fragment derived from the 3’ end of Orsay virus RNA1 was used to 




3.3 Development of an assay for the identification of VSRs in C. elegans  
To facilitate the discovery and characterization of VSRs in C. elegans, we developed an 
RDVI suppression assay based on the induction of RDVI by the self-replication of the genomic 
RNA1 of FHV. The construction of FR1gfp, an FHV RNA1 based replicon that contains a green 
fluorescent protein (GFP) coding sequence in the place of B2 coding sequence (Figure 3.2 panel 
A), was described previously (62). As shown previously, the replication of FR1gfp launched 
from a chromosomally integrated transgene is suppressed by RDVI in wild type worms but is 
restored to yield green fluorescence expressed from the subgenomic RNA produced after RNA1 
replication in RNAi-defective mutant worms such as rde-1 and drh-1 mutants. We determined if 
the FR1gfp-induced RDVI was suppressed and expression of GFP was activated following 
ectopic expression of a functional VSR. We chose the FHV B2 as the VSR since it exhibits 
RNAi suppression activity following ectopic expression in both plant and insect cells and 
suppresses FHV RNA1-induced RDVI when encoded in cis (7, 12). In our experimental system, 
two plasmid constructs were co-microinjected into the gonad of young adult worms containing 
the FR1gfp replicon (62) and GFP expression was monitored in the next generation of worms. 
The first constructs directed expression of the FHV B2 driven by the same heat inducible 
promoter used to initiate FR1gfp replication (Figure 3.2 panel A). The second construct directed 
mCherry expression in the pharynx tissue and was used to generate a visible marker for 
transgene transformation. Most of the extrachromosomal transgenic arrays generated through 
gonad injection are randomly passed on to the next generations so that there are always some 
worms within each generation of the transgenic lines that are free of the transgene, marked by 
the absence of mCherry expression. Therefore, progenies from a transformed parent often 





Figure 3.2 Ectopic expression of FHV B2 suppresses worm RDVI targeting FR1gfp replicon. A. 
Schematic structure of the FR1gfp replicon, the Pmyo-2::mCherry reporter construct, and the 
FHV B1 and B2 transgenes utilizing the heat inducible promoter. HIP, heat inducible promoter. 
Protein A, the replicase of FHV. Rz, the self-cleaving ribozyme sequence from hepatitis delta 
virus. UTR, the 3’ end untranslated sequence of the worm gene unc-54. Pmyo-2, the promoter 
for the worm gene myo-2, which directs target gene expression in the pharynx tissue. B. 
Visualization of green fluorescence in worms carrying the FR1gfp nuclear transgene and 
extrachromosmal array corresponding to FHV B1 or FHV B2, as indicated, 48 hours post heat 
induction. Shown here are merged images recorded using the same exposure under white light, 
red fluorescence and green fluorescence. Worms showing red or orange (merged from red and 
green) color are transgenic for FHV B1 or FHV B2. C. Accumulation of FR1gfp genomic and 
subgenomic RNAs in wild type N2 worms or worms carrying the rde-1 null allele (ne300) or 
integrated transgene corresponding to FHV B1 or B2 as indicated. Total RNA was prepared 48 
hours post heat induction. The total RNA was hybridized with probes prepared from full length 
gfp cDNA. Methylene blue stained ribosomal RNA serves as equal loading control. D. 
Accumulation of FR1gfp transcripts in N2 worms expressing FHV B1 or B2 utilizing the sur-5 
promoter or the heat inducible promoter (indicated with asterisks). 
As shown in Figure 3.1 panel B, we found that all transgenic progenies carrying the 
HIP::fB2 extrachromosomal arrays, marked by red fluorescent in head, produced bright full body 
green fluorescence in response to induction of FR1gfp replication through heat treatment. 
However, no full body green fluorescence was observed in the progenies carrying the transgenic 
arrays that directed expression of FHV B1, which was encoded by the same subgenomic RNA as 
B2 but showed no VSR activity (7). To further verify these findings, we generated chromosomal 
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integrants for the FHV B1 and B2 transgenes and checked the accumulation of FR1gfp 
transcripts in response to heat induction in respective transgenic worms using Northern blot  
hybridization. As shown in Figure 3.2 panel C, enhanced FR1gfp replication was detected in 
FHV B2 chromosomal integrants as found in the rde-1 mutant worms defective in RDVI, but not 
in the integrants containing FHV B1 transgene. These results together showed that ectopic 
expression of FHV B2 suppressed the replicon-induced RDVI in adult worms, indicating that 
rescue of the VSR-deficient FR1gfp replicon could serve as an RDVI suppression assay to 
identify VSRs in C. elegans following heat inducible expression.  
            We next determined if RDVI was suppressed by FHV B2 driven by a constitutive 
promoter. We found that the replication of FR1gfp was also significantly enhanced in worms 
constitutively expressing FHV B2 compared to that in worms constitutively expressing the B1. 
However, in comparison, the expression of FHV B2 utilizing the heat inducible promoter 
achieved a stronger rescue on FR1gfp replication (Figure 3.2 panel D).  
3.4 The genomic RNA2 of Orsay virus encodes no detectable RDVI suppression activity          
The fact that the replication of Orsay virus in wild type N2 worms is suppressed by RDVI 
and can be rescued by FHV B2 suggested that Orsay virus encodes weak or no RDVI 
suppression activity. As an effort to test this hypothesis we subjected the putative capsid protein 
and the delta protein encoded by Orsay virus genomic RNA2 to the RDVI suppression assay 
described in Figure 3.2. Our gonad microinjection of plasmid constructs containing either the 
capsid protein or the delta protein coding sequence driven by the heat inducible promoter (Figure 
3.3 panel A) generated 17 and 13 lines of transgenic worms respectively. However, none of these 
transgenic lines showed enhanced GFP fluorescence after heat induction (Figure 3.3 panel B). 
This result suggests that none of the two putative proteins encoded by Orsay virus RNA2 




Figure 3.3 The genomic RNA2 of Orsay virus encodes no RDVI suppression activity. A. 
Schematic structure of heat inducible transgenes corresponding to the putative coat protein (CP) 
and delta protein of Orsay virus respectively. B. Visualization of green fluorescence in worms 
carrying the FR1gfp nuclear transgene and extrachromosmal arrays generated through gonad 
injection of HIP::CP or HIP::delta. Worms showing red or orange (merged from red and green) 
color carry the HIP::CP or HIP::delta transgene. See Figure 3.2 for experiment details. 
3.5 NoV B2, but not TBSV p19, TAV 2b or hypovirus p29, suppresses RDVI in C. elegans 
Both TBSV p19 and TAV are well-characterized VSRs of plant origin that specifically 
bind and suppress the function of 21 nt siRNA duplexes (35-37, 41). In particular, TBSV p19 is 
known to be functional in heterologous systems such as insect and mammalian (41-43) and, 
owing to its target specificity, has been used as a genetic tool to explore the molecular 
mechanism of 21 nt siRNAs or miRNAs (31, 41). The p29 protein encoded by fungus-infecting 
hypovirus is another VSR known to be able to suppress RNAi in heterologous system such as 
plants (113). Currently, how p29 suppresses RDVI remains largely unknown. To find out 
whether these three VSRs retain their RDVI suppression activity in worm, we subjected all of 
them to the RDVI suppression assay described in Figure 3.2. Our assay also included NoV B2 
which, despite sharing limited sequence identity with FHV B2, adopts a similar mechanism as 
FHV B2 to suppress RNAi (40) thus was expected to retain the RDVI suppression activity in 
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worms. Indeed, as shown in Figure 3.4 panel A&B, ectopic expression of NoV B2 utilizing the 
heat inducible promoter led to successful rescue of FR1gfp replication, manifested as 
significantly enhanced GFP fluorescence, in wild type N2 worms. Surprisingly, such a rescue 
was not observed for ectopic expression of TBSV p19, TAV 2b, a p19 loss of function mutant 
termed p19m, that contains the R72G point mutation (114), or hypovirus p29 (data not shown). 
Consistent with this observation, enhanced FR1gfp replication was detected by Northern blotting 
only in chromosomal integrants containing the heat inducible NoV B2 transgene (Figure 3.4 
panel C).  
       Previous study suggested that TBSV p19 can be tagged with an HA epitope tag to the 
carboxyl-terminus (C-terminus) without losing its RNAi suppression activity (41). To rule out 
the possibility that the failure of TBSV p19 in suppressing worm RDVI is a result of instability 
of this suppressor when produced in worm we checked the accumulation of HA-tagged p19 
expressed from a heat inducible transgene, termed HIP::p19HA (Figure 3.4 panel D, upper left 
panel), using Western blotting. As shown in the lower left panel of Figure 3.4 panel D, the 
production of HA-tagged p19 can be readily detected 48 hours post heat induction in 
chromosomal integrant containing the HIP::p19HA transgene. Like that found for wild type 
TBSV p19, no RDVI suppression activity was detected for this HA-tagged variant (Figure 3.4 
panel D, right panel). These results thus confirmed that the failure of TBSV p19 in RDVI 
suppression is not a result of instability in worm. 
         To find out whether TBSV p19, TAV 2b and NoV B2 are able to suppress dsRNA 
triggered RNAi and RDVI targeting Orsay virus we checked the gfp transgene silencing 





Figure 3.4 NoV B2, but not TBSV p19 or TAV 2b, suppresses long dsRNA triggered RNAi and 
RDVI targeting Orsay virus. A. Schematic structure of heat inducible transgenes corresponding 
to NoV B2 (nB2), TBSV p19 (p19), TBSV p19m (p19m), TAV 2b (2b) and p29. B. 
Visualization of green fluorescence in worms carrying the FR1gfp replicon transgene and 
extrachromosmal arrays generated through gonad injection of constructs shown in A. Shown 
here are merged images recorded under white light, red fluorescence and green fluorescence with 
the same exposure 48 hours after heat induction. C. Accumulation of FR1gfp transcripts in 
transgenic N2 worms carrying the integrated transgenes corresponding to NoV B2, TBSVp19, 
TBSV p19m and TAV 2b. p19m, a p19 variant that contains the R72G point mutation and is 
known to be deficient in RNAi suppression. D. HA-tagged TBSV p19 is deficient in RDVI 
suppression. Upper left panel, the structure of a heat inducible transgene expressing TBSV p19 
tagged with HA at the C-terminus. Lower left panel, Western blot detection of HA-tagged p19 
produced in wild type N2 worms and worms containing the heat inducible transgene shown in 
upper left panel. Right panel, the HA-tagged TBSV p19 is deficient in RDVI suppression. 
Shown here is the accumulation of FR1gfp transcripts detected in wild type N2 worms and 
worms containing the heat inducible transgene corresponding to HA-tagged p19. Asterisks 
denote samples prepared using heat induced worms. E. NoV B2, but not TBSV p19 or TAV 2b, 
suppresses dsRNA triggered RNAi targeting a gfp transgene. Asterisks denote total RNA 
samples extracted from worms fed on E. coli food expressing gfp dsRNA. F. NoV B2, but not 
TBSV p19 or TAV 2b, enhances the replication of Orsay virus. Shown here is the accumulation 
of Orsay virus RNA1 in worms containing NoV B2, TBSV p19 and TAV 2b transgenes, as 
indicated, utilizing the constitutively active promoter of the sur-5 gene.  
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type N2 worms constitutively expressing each of these suppressors. As shown in Figure 3.4 
panel E, the suppression on dsRNA triggered gfp transgene silencing was only observed in NoV  
B2-expressing worms. Consistent with this observation, enhanced Orsay virus replication, 
compared to that in wild type N2 worms, only occurred in worms transgenic for NoV B2 (Figure 
3.4 panel F). These observations together suggested that NoV B2, but not TBSV p19 or TAV 2b, 
suppresses dsRNA triggered RNAi and RDVI triggered during natural viral infection in C. 
elegans. 
3.6 FHV B2 targets a step downstream of primary siRNA biogenesis to suppress RDVI 
To better understand the molecular mechanism underlying the success/failure of the 
nodavirus B2s, TBSV p19 and TAV 2b in worm RDVI suppression we examined the 
accumulation of FR1gfp-derived siRNAs in worms containing heat inducible transgene 
corresponding to each of these VSRs. Consistent with previous deep sequencing analysis (115), 
our Northern blotting analyses detected discrete primary siRNA bands with the major one 
showing up at the position corresponding to 23 nt in the rde-1 mutants which are known to 
accumulate only primary siRNAs (Figure 3.5 panel A) (62, 103, 116). As indicated by arrows in 
Figure 5 panel A, our Northern blot analyses also detected an siRNA band with a size falling 
between 21 and 22 nt in wild type N2 worms and worms containing heat inducible transgene 
corresponding to FHV B1. However, such a siRNA band was not detected in single or double 
mutants containing the rrf-1 null allele. In the light of the fact that rrf-1 functions downstream of 
rde-1 to produce 22 nt secondary siRNAs in a Dicer-independent manner (101, 102, 116, 117) 
we believed that this band represents the rrf-1-dependent secondary siRNAs. The faster 
migration rate of this band compared to the 22 nt primary siRNAs may be a manifestation of the 
fact that the rrf-1-dependent siRNAs carry a triphosphate group at the 5’ end. FR1gfp-derived 
siRNAs were also detected in FHV B2 and NoV B2 transgenic worms with a pattern similar to 
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that detected in rde-1 mutants (Figure 3.5 panel A&B), suggesting that FHV B2 and NoV B2 
inhibit the function, rather than the biogenesis of primary siRNAs to suppress RDVI. In 
agreement with this notion, the rrf-1-dependent secondary siRNAs were not detected in the 
presence of FHV B2 (Figure 3.5 panel A & B). As shown in Figure 3.5 panel A, the 
accumulation of miR-58 was not reduced in response to FHV B2 expression compared to that in 
wild type N2 worms or worms expressing FHV B1, suggesting that FHV B2 does not suppress 
the biogenesis of worm miRNAs.   
         As shown in Figure 3.5 panel C, the rrf-1-dependent siRNAs were also detected in worms 
expressing TBSV p19, TAV 2b or their loss of function mutants with a pattern similar to that 
detected in wild type N2 worms. However, it is interesting to note that despite of the fact that 
none of TBSV p19, TAV 2b and their loss of function mutants exhibited RDVI suppression 
activity in our FR1gfp replication rescue assays (Figure 3.4), a slightly enhanced accumulation 
of 22 nt primary siRNAs was detected in worms expressing wild type TBSV p19 or TAV 2b 
compared to worms expressing respective loss of function mutants (Figure 3.5 panel C). 
           To find out whether FR1gfp-derived siRNAs detected in the presence of FHV B2 are 
bona fide primary siRNA duplexes produced by worm Dicer we treated our small RNA samples 
with Terminator exonuclease which destroys single-stranded RNAs carrying mono-phosphate 
group at the 5’ end but is much less efficient in digesting siRNA duplexes carrying 
monophosphate at the 5’ end (118). As expected, our Terminator treatment destroyed the miR-58 
miRNAs in all small RNA samples (compare the treated samples with the untreated fB1 and fB2 
small RNA samples) (Figure 3.5 panel D). However, such a treatment generated no detectable 




   
Figure 3.5 FHV B2 targets a step downstream of the primary siRNA biogenesis to suppress 
RDVI. A. The accumulation of FR1gfp-derived siRNAs, detected by Northern blotting, in 
worms containing heat inducible transgene corresponding to FHV B1 or FHV B2 and wild type 
N2 worms and single and double mutants defective in rde-1 and/or rrf-1 function as indicated. 
After the detection of the virus-derived siRNAs, the same filter membrane was reused, after 
stripping, for the detection of miR-58 miRNAs. M, four DNA oligos with different sizes as 
indicated. They were detected using DIG-labeled complementary DNA oligos and, together with 
miR-58, served as size reference. The accumulation of miR-58 in each sample also served equal 
loading control. Arrows indicate the rrf-1-dependent siRNAs. B. Shown here is the accumulation 
of FR1gfp-derived siRNAs in rde-1 mutants and worms containing heat inducible FHV B2 or 
NoV B2 transgenes. C. Shown here is the accumulation of FR1gfp-derived siRNAs in rrf-1 
mutants and worms containing heat inducible transgenes corresponding to, as indicated, TBSV 
p19, TAV 2b or their loss of function mutants. 2bm, a loss of function mutant of TAV 2b, which 
contains the P41A point mutation (36). To get size reference and equal loading control, the same 
filter membrane was re-probed for the detection of miR-58 miRNAs. D. Northern blot detection 
of FR1gfp-derived siRNAs in transgenic N2 worms containing heat inducible transgenes 
corresponding to various VSRs, as indicated, after treatment with the Terminator exonuclease. 
After the detection of the virus-derived siRNAs, the same filter membrane was reused for the 
detection of miR-58 miRNAs to generate size reference and equal loading control and 




This result thus suggested that the siRNAs detected in the presence of FHV B2 are bona fide 
primary siRNA duplexes. 
 3.7 FHV B2 does not inhibit the function of worm miRNAs 
In plants, VSRs are capable of interfering with the function of miRNAs, leading to 
development defects (44, 47, 48). The C. elegans genome encodes a single Dicer that is required 
for the biogenesis of both siRNAs and miRNAs (93, 119). The fact that the accumulation of 
miR-58 is not affected in worms expressing FHV B2 (Figure 3.5 panel A&B) suggested that 
FHV B2 does not suppress the biogenesis of worm miRNAs. However, heat inducible expression 
of FHV B2 exhibited stronger suppression on RDVI, compared to constitutive expression 
(Figure 3.2 panel D), suggested a hypothesis that constitutive expression of FHV B2 leads to the 
suppression on miRNA function such that worms constitutively expressing FHV B2 at high level 
failed to develop and thus were selected out. To test this hypothesis we checked the suppression 
activity of FHV B2 on miRNA function using an assay system developed previously (111). This 
assay system features a myo-2 promoter driven gfp transgene containing the let-7 target 
sequences within the 3’ end untranslated region. Thus, suppression of miRNA function will 
result in enhanced green fluorescence in the pharynx tissue which can be easily identified.  
        We used the myo-2 promoter to drive the expression of FHV B2 and the control protein 
FHV B1 in our assay to ensure that both transgenes will have the same tissue-specific expression 
pattern as the gfp reporter gene (Figure 3.6 panel A). To ensure that functional FHV B2 proteins 
are produced in the pharynx tissue, we checked the suppression activity of FHV B2 on RNAi 
triggered by two transgenes that produce complementary transcripts within the pharynx tissue. 
As shown in Figure 3.6 panel A, the Pmyo-2::GFP construct contains a GFP coding sequence 
under the control of myo-2 promoter whereas the Pmyo-2::PFG construct contains a sequence 
complementary to the GFP coding sequence under the control of the same myo-2 promoter. Thus, 
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co-delivery of Pmyo-2::GFP and Pmyo-2::PFG constructs is expected to trigger gfp silencing in 
wild type N2 worms. Indeed, as shown in Figure 3.6 panel B, a transgenic locus containing both 
Pmyo-2::GFP and Pmyo-2::PFG transgenes produced weak green fluorescence in wild type N2 
worms but bright green fluorescence in rde-4 mutants. Enhanced green fluorescence produced by 
the same transgenic locus was also observed in wild type N2 worms containing the Pmyo-2::fB2 
transgene. However, such an enhancement in green fluorescence was not observed in the 
presence of the Pmyo-2::fB1 transgene, confirming that the Pmyo-2::fB2 transgene produces 
functional FHV B2 in the pharynx tissue.  
      
 
Figure 3.6 FHV B2 does not inhibit miRNA function. A. Schematic structure of the myo-2 
promoter based constructs. PFG, the antisense of GFP coding sequence. B. FHV B2 suppresses 
RNAi in the pharynx tissue. Shown here is the green fluorescence in pharynx tissue in wild type 
N2 worms, rde-4 mutants and worms containing Pmyo-2::fB1 or Pmyo-2::fB2 transgene as 
indicated. All worms used in this test contain a nuclear transgene generated by co-injection of 
Pmyo-2::GFP and Pmyo-2::PFG. The images were produced by merging images recorded using 
the same exposure under white light, red fluorescence or green fluorescence. C. FHV B2 does 
not suppress miRNA function in C. elegans. Shown here is the green fluorescence in the pharynx 
tissue in wild type N2 worms and worms containing extrachromosomal array corresponding to 
Pmyo-2::fB1 or Pmyo-2::fB2 as indicated. The images were produced by merging images 
recorded under white light or green fluorescence with the same exposure. The insets are images 
recorded under white light. 
      To find out whether FHV B2 suppresses the function of miRNAs, we injected the wild type 
N2 worms carrying the gfp reporter transgene with Pmyo-2::fB1 or Pmyo-2::fB2 constructs. 
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Subsequently, we checked the production of green fluorescence in worms containing 
extrachromosomal arrays corresponding to Pmyo-2::fB1 or Pmyo-2::fB2. As shown in Figure 
3.6 panel C, no enhanced green fluorescence was observed in response to ectopic expression of 
either FHV B1 or FHV B2, suggesting that FHV B2 does not interfere with the function of 
miRNAs in C. elegans. 
3.8 Conclusions 
      By developing an assay, based on rescue of mutant Flock house virus replication described 
above, I have successfully identified Nodovirus B2, which shares limited sequence homology 
with Flock house virus B2 but uses similar mechanism in RDVI suppression, as another viral 
suppressor that retains RDVI suppression activity in the worm system, confirming the robustness 
of this assay system. Notably, no VSR activity was detected for either of the coat protein or delta 
protein of Orsay virus proposed previously as VSRs. Among other known heterologous VSRs, 
no functional suppressor activity detected for 2b of tomato aspermy virus (TAV), p29 of fungus-
infecting hypovirus, or p19 of tomato bushy stunt virus (TBSV). Since p19 is known to 
specifically bind 21 nt siRNA to suppress RDVI, I concluded that siRNAs of 21 nt do not make 
major contribution in RDVI. Further, unlike that in plants and insects, FHV B2 suppresses worm 
RDVI mainly by interfering with the function of virus-derived primary siRNAs, but not affecting 
the primary siRNA biogenesis. Furthermore, ectopic expression of Flock house B2 in the 
pharynx of worms with miRNA sensor construct indicated that B2 does not affect miRNA 
function. Thus, this assay system for the first time makes it possible to identify VSRs with worm 
RDVI suppression activity. It can be expected that functional and mechanistic characterization of 
VSRs identified using this assay will help unravel some unique features of VSR-mediated virus-




CHAPTER 4 SILENCING OF HOST GENES DIRECTED BY VIRUS-
DERIVED SIRNAS IN CAENORHABDITIS ELEGANS1 
4.1 Introduction 
Small interfering RNAs (siRNAs) processed from viral replication intermediates, by 
ribonuclease III-like enzyme Dicer, guide sequence-specific antiviral silencing in fungi, plants 
and invertebrates. In plants, virus-derived siRNAs (viRNAs) can target and silence cellular 
transcripts and in some cases are responsible for the induction of plant diseases. Currently, it 
remains an open question whether viral derived siRNAs have the potential to modulate host gene 
expression in the animal kingdom as well. The nematode worm C. elegans would be an animal 
model of particular interest to address this question, considering the fact that, like plants, C. 
elegans produces four RNA-dependent RNA Polymerases (rrf-1～3, and ego-1) as important 
amplifying components of RDVI. In this chapter, I developed a modified Flock house virus 
replicon (FR1FP), in which only half of 3’ end GFP sequence is used to replace B2, and tested 
whether it replicates to trigger antiviral silencing and whether the antiviral silencing triggered by 
this particular replicon can be redirected to target homologous transgene and host transcripts 
(unc-22, skn-1) in the nematode C. elegans.  
4.2 Development of an FHV RNA1 based replicon for the test of VIGS in C. elegans   
FHV is a representative member of the nodavirus family that features bipartite genomes 
of plus-polarity. The genomic RNA1 of FHV can replicate autonomously, producing a 
subgenomic RNA, the RNA3 (Figure 4.1 panel A). The RNA3 encodes an RNA silencing 
suppressor called B2, which suppresses RDVI in diverse organism species, including C. elegans 
(7, 9). The genomic RNA2 of FHV encodes the viral coat protein and its replication requires the 
                                                 
1 “Part of this chapter previously appeared as [Guo X, Li WX, and Lu R, Silencing of Host Genes 
Directed by Virus-Derived Short Interfering RNAs in Caenorhabditis elegans, August 2012]. It is 
reprinted by permission of [Copyright © American Society for Microbiology—see appendix]” 
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protein A, the viral replicase produced by the genomic RNA1. Recently, two nodaviruses have 
been found to naturally infect the nematode worms C. elegans and C. briggsae respectively, 
making FHV an ideal model virus for the study of virus-host interaction in nematodes (50). 
Importantly, when delivered through a transgene strategy, the FHV RNA1, or its derivative, can 
replicate autonomously to trigger potent RDVI in C. elegans, making it a perfect, owing to its 
small size and simple structure, viral agent for the study of cytosolic antiviral mechanism, such 
as RDVI, in the nematodes (9, 62).  
          Previously, an FHV RNA1 based replicon, named FR1gfp, has been shown to replicate 
and trigger potent RDVI in C. elegans (62). The FR1gfp replicon was created by replacing the 
B2 coding sequence with that coding for enhanced green fluorescence protein (GFP). In order to 
test VIGS in C. elegans using a gfp transgene as a reporter, we generated a new FHV RNA1 
based replicon called FR1fp. The FR1fp features the 3’ end half of gfp coding sequence, 341 bp 
in length, in the place of B2 coding sequence (Figure 4.1 panel B). To find out whether FR1fp 
can perform self-replication to trigger RDVI in C. elegans, we generated a chromosomal 
integrant carrying the FR1fp replicon and checked its replication in different genetic 
backgrounds. As shown in Figure 4.1 panel C, FR1fp replication, manifested as the production of 
the subgenomic RNA3, was detectable in wild type N2 worms but became significantly 
enhanced in worm mutants corresponding to rde-1, rde-4 and rrf-1. Since rde-1, rde-4 and rrf-1 
are known genes with important functions in worm RDVI (8, 19, 62), this result confirmed that 
FR1fp indeed replicates and triggers potent RDVI in C. elegans. 
         In C. elegans, rde-4, but not rde-1, is required for the biogenesis of discrete classes of 
primary viRNAs that can be detected by northern blot (62). To find out whether the FR1fp 




Figure 4.1 Development of the FR1fp replicon. A. Schematic structure and replication of FHV 
RNA1 and RNA2. Protein A, the replicase of FHV. B2, the RNA silencing suppressor. RNA3, 
the subgenomic RNA of RNA1. B. Structure of the FR1fp replicon.  HIP, the heat inducible 
promoter from worm gene hsp-16.41. FP, the 3’ end half of GFP coding sequence. Rz, the self-
cleaving ribozyme sequence of hepatitis delta virus. UTR, the 3’ end untranslated region of unc-
54. C. Accumulation of FR1fp genomic (RNA1) and subgenomic (RNA3) RNAs in different 
genetic backgrounds as indicated in response to heat induction. The FR1fp transcripts were 
detected using probes corresponding to the FP region of FR1fp. Methylene blue stained 
ribosomal RNA (rRNA) serves as equal loading control. D. Accumulation of FR1fp-derived 
viRNAs in different genetic backgrounds as indicated. The viRNAs were detected using DIG-
labeled DNA oligos corresponding to the FP region of FR1fp. The accumulation of miR-58 
detected by northern blot serves as both size reference and equal loading control. 
viRNA detection using DNA oligo probes that cover the entire FP region. As shown in Figure 
4.1 panel D, in agreement with previous findings, high-level accumulation of viRNAs derived 
from the FP region was detected in rde-1 mutants but not in rde-4 mutants. The viRNAs also 
accumulated in rrf-1 mutants, at a lower level, with a similar size distribution as that in rde-1 
worms. It is worth noting that the viRNAs were also detected in the wild type N2 worms with a 
major band appearing at around 22nt. Considering the fact that the abundance of primary 
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viRNAs in C. elegans peaks at 23 nt (62, 115), the 22 nt viRNAs detected in N2 background 
may represent the secondary siRNAs produced by RRF-1. 
4.3 FR1fp replication triggers potent silencing of a gfp transgene 
To have a quick test on VIGS targeting a constitutively expressed gfp transgene in C. 
elegans, we injected the FR1fp construct, together with an mCherry reporter construct, into the 
gonads of worms carrying a nuclear gfp transgene driven by the sur-5 promoter (Figure 4.2 panel 
A). The mCherry reporter construct directs mCherry expression in worm pharynx tissue thus will 
serve as a visual mark for the FR1gfp transgene. Since both the sur-5 promoter and the promoter 
driving FR1fp primary transcription are active in most C. elegans cells (110, 120), the silencing 
of the gfp transgene is expected to occur in response to heat induction if C. elegans indeed 
supports VIGS. Indeed, of 13 transmittable lines obtained, most adult worms carrying the extra-
chromosomal arrays corresponding to the FR1fp, manifested as red fluorescence in the pharynx 
area, exhibited reduced gfp expression, compared to worms that do not carry the transgene, 48 
hours post heat induction. To confirm that the reduction in gfp expression is resulted from RNA 
silencing, we generated a chromosomal integrant for the FR1fp replicon and checked gfp 
expression in worm mutants defective in RNA silencing after heat induction. As shown in Figure 
4.2 panel B, the expression of the gfp transgene, manifested as green fluorescence, was markedly 
reduced in wild type N2 worms in response to heat induction. However, such a reduction did not 
occur in RNA silencing defective mutants corresponding to rde-1 or rde-4 despite of high-level 
replication of the FR1fp in both mutants (Figure 4.2 panel C). rde-4 and rde-1 are known to play 
essential roles in primary siRNA biogenesis and function respectively. These results thus 
confirmed that the down-regulation of gfp expression observed in this test is indeed mediated by 
RNA silencing. The gfp silencing also occurred in the rrf-1 knockouts but to a lesser extent 
compared to that in wild type N2 worms (Figure 4.2 panel B&C). Since the rrf-1 products are 
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known to be responsible for the production of secondary siRNAs, this test further suggested that 
both primary and secondary viRNAs mediate target destruction in VIGS in C. elegans.  
 
 
Figure 4.2 The FR1fp replication triggers potent silencing of a gfp transgene. A. The structure of 
the transgene expressing enhanced GFP and the Pmyo-2::mCherry reporter construct. Psur-5, the 
promoter of worm gene sur-5. Pmyo-2, the promoter of the myo-2 gene. B. The comparison of 
green fluorescence intensity in between worms that carry the FR1fp replicon, manifested as red 
fluorescence in head, and those that do not in different genetic backgrounds as indicated after 
heat induction. All worm strains carry the same nuclear transgene corresponding to the Psur-
5::GFP. Showed here are merged images recorded under white light, red fluorescence and green 
fluorescence. C. The accumulation of the gfp transcripts and FR1fp RNAs in the worm strains 
shown in B before and after heat induction. Phosphotase labeled DNA probes corresponding to 
the FP region of FR1fp were used for viral RNA detection. The gfp transcripts were detected 
using probes derived from the 5’ end of GFP coding sequence that does not overlap with the FP 
region of the FR1fp. D. The accumulation of the gfp transcripts and FR1fp RNAs in sid-1 
knockouts as compared to that in N2 background in response to heat induction. 
          In C. elegans, RNA silencing involves an intercellular silencing signal that guides 
sequence-specific silencing in distant tissues/cells, a phenomenon termed systemic silencing 
(121, 122). A recent study further suggested that it is the long dsRNAs and/or primary siRNAs 
that act as or generate the mobile silencing signal (70). To find out whether the gfp silencing 
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triggered by FR1fp replication involves systemic silencing, we checked the FR1fp induced gfp 
silencing in the sid-1 knockout mutants. SID-1 is a C. elegans transmembrane protein that 
functions as a dsRNA-selective dsRNA-gated channel in systemic silencing (68, 69). We 
reasoned that if the FR1fp triggered gfp silencing in some cells is initiated by an intercellular 
silencing signal rather than by FR1fp derived viRNAs, the gfp silencing will be compromised in 
sid-1 knockouts as compared to that in wild type N2 worms. As shown in Figure 4.2 panel D, the 
gfp silencing triggered by FR1fp in sid-1 mutants containing the qt2 allele is comparable to that 
in wild type N2 worms. It was also clear that the FR1fp replicated to comparable levels in the 
sid-1 knockouts and the wild type N2 worms. Based on this test, we concluded that the gfp 
silencing triggered by FR1fp in this report is mainly intracellular silencing.  
4.4 The replicating FR1fp is the only trigger of the VIGS targeting the gfp transgene  
In plants, RNA silencing can be triggered by transient expression of homologous 
sequences. It is believed that dsRNAs formed through overlapped bidirectional transcription of 
the same sequences serve as the trigger (123). To confirm that the gfp silencing described in 
Figure 4.2 is indeed triggered by viRNAs derived from replicating FR1fp rather than transient 
over-production of the FR1fp primary transcripts, we changed the trigger replicon from FR1fp to 
a replication deficient mutant named FR1fpfs (Figure 4.3 panel A). The FR1fpfs was created by 
introducing a frame-shift mutation into the protein A coding sequence in FR1fp. Apparently, the 
FR1fpfs retains all of the biological properties needed for being replicated by a functional 
replicase provided in trans, since co-injection of FR1fpfs and the HIP::protein A construct 
(Figure 4.3 panel A), which carries wild type FHV protein A coding sequence under the control 
of the same heat inducible promoter, can rescue the replication of FR1fpfs (data not shown). To 
find out whether transient production of the FR1fpfs primary transcripts can trigger the silencing 
of the gfp transgene, we injected the FR1fpfs construct, together with the mCherry reporter 
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construct (Figure 4.2 panel A), into the N2 worms carrying the Psur-5::GFP transgene. Of 7 
transgenic lines carrying the FR1fpfs extra-chromosomal arrays, no gfp silencing was observed 
after heat induction (Figure 4.3 panel B). To rule out the possibility that the lack of gfp silencing 
is due to the failure in the FR1fpfs primary transcript production, we checked the accumulation of 
FR1fpfs transcripts in response to heat induction using northern blot. As shown in Figure 4.3 
panel C, FR1fpfs transcripts were detected 12 hours post heat induction. These results together 
suggested that the gfp silencing in our setup is indeed induced by replicating FR1fp that produces 
viRNAs in an RDE-4-dependent manner.  
  
Figure 4.3 The gfp silencing shown in Figure 4.2 is triggered by replicating FR1fp. A. The 
schematic structure of FR1fpfs and FR1RdRP. Protein A, the replicase of FHV, an RdRP. B. 
Green fluorescence visualized in gfp transgenic worms carrying extrachromosomal arrays 
corresponding to FR1fp and FR1fpfs respectively before and after heat induction. All worms in 
this test contained the same gfp transgene as described in Figure 4.2 panel B. The 
extrachromosomal arrays were generated through gonad injection of target constructs together 
with reporter construct Pmyo-2::mCherry (Figure 4.2 panel A). Shown here are merged images 
recorded under white light, red fluorescence and green fluorescence 48 hours post heat induction. 
C. The comparison of gfp silencing in response to heat induction in between worm strains 
carrying the extrachromosomal arrays corresponding to FR1fp or FR1fpfs. D. Upper panel, 
structure of the FR1∆B2 replicon. Lower panel, the comparison of gfp silencing in response to 
heat induction in between worm strains carrying the extrachromosomal arrays corresponding to 
FR1fp or FR1∆B2 replicon. 
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To confirm that the gfp silencing is indeed induced by viRNAs derived from replicating 
FR1fp rather than an artifact resulted from the replication of non-specific viruses, we switched 
the triggering replicon from FR1fp to FR1∆B2. FR1∆B2 contains a point mutation that disrupted 
the start codon of the B2 ORF thereby to sensitize the virus to RDVI (Figure 4.3 panel D, upper 
panel) (9). As a result, replicon of FR1∆B2 in wild type N2 worms will induce the production of 
viRNAs that are not complementary to the gfp mRNAs. Thus, no gfp silencing should occur in 
response to FR1∆B2 replication. As shown in Figure 4.3 panel D, lower panel, the gfp silencing 
did not occur in response to FR1∆B2 replication. These results together suggested that the gfp 
transgene silencing described in Figure 4.2 is indeed triggered by viRNAs derived from 
replicating FR1fp.  
4.5 VIGS is inheritable in C. elegans 
In C. elegans, RNA silencing induced by exogenous dsRNAs is inheritable (124). A 
recent report demonstrated that antiviral silencing in C. elegans also features a non-Mendelian, 
multigenerational inheritance and that it is the viRNAs that serve as physical carrier of the 
silencing signal across generations (125). Considering the fact that viRNAs are capable of 
mediating potent silencing of cellular transcripts as described above, it would be of interest to 
ask whether VIGS can be transmitted to the next generation. To address this question, we 
initiated gfp silencing by heat inducing the transgenic worms carrying both the gfp transgene and 
the FR1fp replicon, as described in Figure 4.2, and checked the gfp silencing in the next 2 
generations (see Figure 4.4 panel A for details). We observed gfp silencing, albeit to a lesser 
extent compared to that in the mothers, in the F1 generation. In agreement with this observation, 
the gfp transcripts of the F1 generation accumulated to a lower level compared to the non-
induced worms as confirmed by northern blot (Figure 4.4 panel B). In the F2 generation, the gfp 
silencing was much less evident compared to that in the F1 generation and accordingly the 
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northern blot failed to detect a decrease in gfp transcript level (Figure 4.4 panel B). As expected, 
no gfp silencing was detected in heat induced mothers or the next two generations when the same 
test was carried out using the rde-1 knockouts. Based on these results, we concluded that VIGS 
in the nematode worms is inheritable. 
 
Figure 4.4 VIGS is inheritable in C. elegans. A. The strategy used to test whether VIGS in C. 
elegans is inheritable. B. The accumulation of the gfp transcripts in heat induced mothers (P0) 
and next two generations (F1 and F2) in wild type N2 or rde-1 knockouts. All worms used in this 
test contained the same gfp nuclear transgene and the same FR1fp replicon as described in Figure 
4.2 panel B. The gfp transcripts were detected 48 hours post heat induction for the mothers.  
4.6 VIGS can target and silence endogenous gene in C. elegans 
unc-22 encodes an abundant myofilament protein required for muscle structure and 
function and reduction in unc-22 expression, e.g. as a result of RNA silencing, produces severe 
twitching phenotype that can be easily identified (1). The fact that VIGS in C. elegans is 
inheritable prompted us to ask whether VIGS is able to target endogenous genes, such as the 
unc-22, thereby to produce RNA silencing phenotypes in the next generation. To address this 
question, we developed a new replicon by replacing the FP region of the FR1fp with an unc-22 
sequence, derived from the exon 7, of the same length. Unfortunately, upon heat induction, the 
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transgenic worms containing the extra-chromosomal arrays corresponding to the new replicon 
did not produce progenies with discernible twitching phenotype (data not shown). We believed 
that the lack of viral replication, thus the accumulation of viRNAs, is responsible for the failure 
of unc-22 silencing since the replication of the new replicon was extremely weak (data not 
shown). Very likely, modification in the RNA3 region of the new replicon has rendered it much 
less efficient in self-replication. 
          FHV replication is often associated with the production of an RNA2-derived defective-
interfering RNA called DI-634 (126). Importantly, the DI-634 can be modified for the expression 
of heterologous genes (127). Thus, as a strategy to circumvent the requirement of self-replicating 
RNA1 to trigger unc-22 silencing, we created a DI-634 based replicon, termed DI634 (Figure 4.5 
panel A). Like that in the FR1fp replicon, the transcription of the DI634 replicon is initiated by 
the same heat inducible promoter and the same self-cleaving ribozyme sequence was attached to 
the 3’ end of the DI634 genome to remove the non-viral sequence after transcription. When the 
DI634 replicon and the FR1∆B2 replicon were co-injected into the drh-1 knockouts, high-level 
accumulation of the DI634 derived RNAs were detected using probes specific to the DI634 
genome (Figure 4.5 panel B). 
          To find out whether VIGS can target and silence the unc-22 gene, we inserted 552 bp unc-
22 coding sequence, derived from the exon 7, into the multiple cloning site (MCS) of the DI634 
replicon and delivered the new replicon, termed DI634unc22 (Figure 4.5 panel A), together with 
the FR1∆B2 replicon, into wild type N2 worms through gonad injection. Upon heat induction, 
the accumulation of DI634unc22-derived transcripts became detectable 8 hours post heat 
induction (phi) and was further enhanced at 24 hours hpi (Figure 4.5 panel C). Accordingly, a 
decrease at the unc-22 mRNA level was detected at 24 hours phi using northern blot. As a result 
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of the decrease in the unc-22 expression, we observed twitching phenotype on approximately 52% 
progenies produced 24 hpi by the N2 mothers whereas no twitching phenotype was observed for 
progenies produced by non-treated mothers or the rde-1 mothers that carry the same transgene 
(Figure 4.5 panel D). Using the same strategy, we also tested the silencing of another 
endogenous gene skn-1, whose function is required for intestine development of early embryos. 
    
 
Figure 4.5 Down-regulation of endogenous gene expression by VIGS. A. Schematic structure of 
the DI634 and the DI634-based replicons DI634unc22 and DI634skn-1. MCS, multiple cloning 
site corresponding to AscI-XhoI-NotI.  unc-22, a cDNA fragment derived from the exon 7 of the 
unc-22 gene. Skn-1, a cDNA fragment derived from the skn-1 coding sequence. B. Replication 
of DI634 in the presence of a functional protein A produced by FR1∆B2 in drh-1 knockouts. The 
replication of FR1∆B2 was detected using cDNA probes derived from the RNA3 of FR1∆B2. 
The replication of DI634 was detected using cDNA probes derived from the DI634 genome. C. 
Down-regulation of the unc-22 expression triggered by replicating DI634unc22. The 
accumulation of the DI634unc22 replication products and the unc-22 transcripts were detected 
using unc-22-specific cDNA probes at different time point as indicated. hpi, hours post heat 
induction. D. The VIGS phenotype resulted from DI634unc22 replication in the F1 progenies. 
Shown here are the percentages of twitching F1 progenies produced by heat induced mother 
containing the DI634unc22 replicon 24 hpi. The error bars indicate standard deviation for the 
twitching phenotype. E. viRNAs mediated potent silencing of the endogenous gene skn-1. 
Shown here are the embryos and worm larvae produced by heat induced N2 and rde-1 mothers 
carrying the same FR1∆B2 and DI634skn-1replicons. 
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Our result, as shown in figure 4.5 panel E, clearly showed that VIGS can target and silencing 
skn-1, leading to the production of dead eggs from heat induced worms carrying the DI634skn-1 
replicon (Figure 4.5 panel A). Based on these results, we concluded that VIGS can target and 
silence endogenous genes in C. elegans.  
4.7 Conclusions 
In this chapter, I show that viral siRNAs derived from FR1FP replicon indeed triggered 
potent silencing of homologous GFP transgene in C. elegans, whereas a replication deficient 
FR1FP replicon failed to induce silencing, confirming that only replicating virus triggers host 
gene silencing in this study. Like that found in plants, virus-induced gene silencing (VIGS) in C. 
elegans also involves RRF-1, a worm RNA-dependent RNA polymerase (RdRP) that is known 
to produce single-stranded secondary siRNAs in a Dicer-independent manner. I further 
demonstrated that VIGS in C. elegans is inheritable, suggesting that VIGS has the potential to 
generate profound epigenetic consequences in future generations. In addition, by using modified 
Flock house virus RNA2 genome that contains part of C. elegans unc-22 or skn-1 coding 
sequence, I demonstrated that viral derived siRNAs are able to modulate endogenous gene 
expression. Altogether, these findings, for the first time, confirmed that viRNAs have the 
potential to regulate host gene expression in the animal kingdom. Most importantly, the success 
in uncoupling the trigger and the target of the antiviral silencing would allow for the exploration 




CHAPTER 5 ANTIVIRAL RNA SILENCING INITIATED IN THE 
ABSENCE OF RDE-4, A DOUBLE-STRANDED RNA BINDING PROTEIN, 
IN CAENORHABDITIS ELEGANS1 
5.1 Introduction 
Small interfering RNAs (siRNAs) processed from double-stranded RNA (dsRNA) of virus 
origin mediate potent antiviral defense through a process referred to as RNA interference (RNAi) 
or RNA silencing in diverse organisms. In the simple invertebrate Caenorhabditis elegans, RNAi 
machinery is initiated by single Dicer, which partners with the dsRNA binding protein RDE-4 to 
process dsRNA into primary viral derived siRNAs (viRNAs), then one of the strands of primary 
viRNA duplex is loaded into the Argonaute proteins (AGO) by thermodynamic mechanism, and 
binds to its complementary mRNA as target. The Argonaute proteins perform “slicer” activity 
for mRNA cleavage and recruit host RNA-dependent RNA polymerase (RdRP) to generate 
secondary viral siRNAs with tri-phosphate groups in the 5’end. Notably, In C. elegans this 
RNA-directed viral immunity (RDVI) also requires a number of worm-specific genes for its full 
antiviral potential. Previous genetic screen through feeding RNAi suggested that RSD-2 (RNAi 
spreading defective 2) is a worm-specific component of RDVI that contributes to RDVI through 
unknown mechanism. Interestingly, RSD-2 was originally identified as a requirement for 
uptaking dsRNA signal into the germline. Later on it was found to be required for chromosome 
segregation. Since RSD-2 is specific to nematodes, it would be interesting to determine through 
what a unique mechanism this worm-specific gene contributes to RDVI. In this chapter, I tested 
whether ectopic expression of wild type RSD-2 is able to rescue RSD-2 function in rsd-2 mutant 
(tm1429). By comparing Flock house virus and Orsay virus replication levels in double mutants 
                                                 
1 “Part of this chapter previously appeared as [Guo X, Zhang R, Wang J and Lu R, Antiviral 
RNA silencing initiated in the absence of RDE-4, a double-stranded RNA binding protein, in 
Caenorhabditis elegans. July 2013]. It is reprinted by permission of [Copyright © American 
Society for Microbiology—see appendix]” 
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corresponding to rsd-2 and other known RDVI genes, such as rde-1, rde-4, and rrf-1, together 
with small RNA profiling, I found that RSD-2 contributes to rde-4-dependent and rde-4-
independent RDVI in C. elegans. 
5.2 rsd-2 is not essential for the biogenesis of primary viRNAs  
           rsd-2 of C. elegans was first implicated in RDVI through an RNAi screen that selected for 
genes whose down-regulation by dsRNA feeding led to loss of RDVI (62). To confirm that the 
loss of RDVI in worms fed with rsd-2-targeting dsRNA was indeed caused by partial loss of rsd-
2 function, we examined the replication of FR1gfp replicon in the mutant worms containing 
tm1429 or pk3307 alleles of rsd-2 respectively. The tm1429 allele contains a 251 nt deletion, 
spanning from nt #1376 to #1626 of rsd-2 cDNA, and is hence predicted to produce a truncated 
RSD-2 that contains only the first 458 amino acid (aa) residues of the 1266 aa wild type RSD-2. 
Conversely, the pk3307 allele contains a premature stop codon in the RSD-2 coding sequence 
that caused the truncation of the last 542 aa of RSD-2. Thus, both rsd-2 alleles are considered as 
null allele. The FR1gfp replicon was developed from flock house virus (FHV) RNA1 by 
replacing the coding sequence of B2, the FHV-encoded RNAi suppressor, with that of green 
fluorescent protein (GFP). As a result, the replication of FR1gfp is subdued by RDVI in wild 
type N2 worms but rescued in RDVI defective worms such as the rde-1 mutants. As shown in 
Figure 5.1 panel A, similar to the rde-1 mutants, both rsd-2 mutants supported elevated 
accumulation of FHV RNAs (Figure 5.1 panel A, compare lanes 3 and 4 with 1 and 2), thus 
confirming a critical role of wild type RSD-2 in FHV-targeting RDVI. Enhanced accumulation 
was also observed in the rsd-2 mutants for Orsay virus, a natural viral pathogen of C. elegans 
that is closely related to FHV (Figure 5.1 panel B, compare lanes 2 and 3 with lane 1) (50). 
These results together strongly suggested that RSD-2 plays an important role in RDVI. 
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To reconfirm that the loss of RDVI in rsd-2 mutants indeed resulted from the rsd-2 null 
alleles but not any other closely linked genetic alleles we checked if ectopic expression of wild 
type RSD-2 restores RDVI in rsd-2 mutants (tm1429) containing the FR1gfp replicon. The 
ectopic expression of wild type RSD-2 coding sequence was achieved through gonad 
microinjection of plasmid construct containing RSD-2 coding sequence driven by the sur-5 
promoter  (figure 5.1 panel C) (110). A plasmid construct that directs mCherry expression in 
pharynx tissue was co-injected to produce a visual reporter for the transgene. As shown in Figure 
5.1 panel C, FR1gfp replication, manifested as green fluorescence, was suppressed in rsd-2 
mutants containing the Psur-5::RSD-2 transgene (compare the worms that showed red 
fluorescence in the heads with worms that did not). Consistent with this observation, FR1gfp 
transcripts were detected at reduced level in worms containing the Psur-5::RSD-2 transgene 
(Figure 5.1 panel D, compare lane 2 with lane3). These results thus confirmed that RSD-2 indeed 
plays an important role in worm RDVI. 
          In C. elegans, the same gene can play distinct roles in different RNAi pathways. For 
example, ergo-1 plays essential role in endogenous RNAi but contributing to the biogenesis of 
endogenous siRNAs but appears to negatively regulate RDVI (62). rsd-2 is known to contribute 
to the accumulation of secondary, but not primary, endogenous siRNAs (66). Currently, whether 
RSD-2 contributes to RDVI through a similar mechanism remains largely unknown. To address 
this question, we checked the accumulation of viRNAs in rsd-2 mutants (tm1429) using Northern 
blotting. Both rde-1 and rde-4 play essential roles in worm RDVI. However, virus-derived 
siRNAs accumulate to readily detectable level in rde-1 but not rde-4 mutants (8, 62). Thus, as a 
control, the accumulation of viRNAs in rde-1 and rde-4 mutants was also detected in this test. As 
shown in Figure 5.1 panel E, although not detectable in wild type N2 worms or rde-4 mutants, 
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FR1gfp-derived viRNAs was detected at high levels in rde-1 mutants with a major band detected 
at the position corresponding to 23-nucleotide (nt). FR1gfp-derived siRNAs were also detected 
 
Figure 5.1 rsd-2 is not essential for the biogenesis of primary viRNA. A. Northern blot to show 
the accumulation of FR1gfp genomic and subgenomic transcripts in different genetic 
backgrounds as indicated. Total RNA was extracted from heat induced worms 48 hours post heat 
induction. The viral transcripts were detected using probes prepared from full length gfp cDNA. 
RNA1, the genomic RNA of FR1gfp. RNA3, the subgenomic RNA of FR1gfp. rRNA, 
methylene blue stained ribosomal RNA serving as equal loading control. B. Accumulation of 
Orsay virus RNA1 (ovRNA1) in wild type N2 worms and rsd-2 mutants carrying tm1429 or 
NL3307 allele as indicated. Total RNA was prepared 72 hours post viral inoculation. Orsay virus 
RNA1 was detected using cDNA probes prepared using a cDNA fragment amplified from the 3’ 
end of Orsay virus RNA1. C. Upper panel, the structure of Psur-5::rsd-2. Psur-5, the promoter 
for endogenous gene sur-5. RSD-2, the coding sequence of wild type rsd-2. UTR, the 3’ end 
untranslated region of unc-54. Lower panel, visualization of green fluorescence in rsd-2 mutants 
(tm1429) carrying the FR1gfp replicon transgene and extrachromosmal array corresponding to 
Psur-5::RSD-2 48 hours post heat induction. Shown here are merged images recorded, using the 
same exposure, under red fluorescence and green fluorescence. Worms showing red color are 
transgenic for Psur-5::RSD-2. D. Accumulation of FR1gfp transcripts in wild type N2 worms, 
drh-1 mutants and rsd-2 mutants (tm1429) with/without the extrachromosomal assay derived 
from Psur-5::RSD-2 construct. RSD-2wt denotes the Psur-5::RSD-2 transgenic array. E. 
Accumulation of FR1gfp-derived siRNAs in wild type N2 worms and RDVI defective mutants 
as indicated. M, four DNA oligos with sizes of 19, 21,23 and 25 nt detected and used, together 
with miR-58, as size references.  
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in rsd-2 mutants with a pattern similar to that in rde-1 mutants but at a visibly lower level. 
Previously, it has been shown that primary siRNAs produced by worm Dicer are predominantly  
23-nt in size and accumulate at high level in rde-1 mutants (103, 115, 128) (92). This result thus 
suggested that rsd-2 is not essential for the biogenesis of primary viRNAs. 
5.3 rsd-2 contributes to rde-4-independent antiviral silencing 
We previously reported that FR1gfp-derived siRNAs detected in drh-1 mutants become 
undetectable in drh-1;rde-4 double mutants, suggesting that drh-1 and rde-4 function in a linear 
genetic pathway (62). To find out whether rsd-2 also functions in the same genetic pathway, we 
compared the accumulation of primary viRNAs in double mutants corresponding to drh-1;rde-4, 
rsd-2;rde-4 and rsd-2;drh-1. As shown in Figure 5.2 panel A, although not detectable in drh-
1;rde-4 double mutants, FR1gfp-derived primary siRNAs were detected in both rsd-2;drh-1 and 
rsd-2;rde-4 double mutants (compare lane 3 with lanes 1 and 4). Most importantly, an enhanced 
replication for both Orsay virus and FR1gfp was observed in rsd-2;rde-4 and rsd-2;drh-1 double 
mutants compared to rde-4 and drh-1 single mutants respectively (Figure 5.2 panel B&C, left 
panels). These observations together suggested an rde-4-independent mechanism that directs 
antiviral silencing in an rsd-2-dependent manner in C. elegans. RDE-1 specifically recruits 
primary siRNAs, but not secondary siRNAs, for target RNA selection and is believed to function 
downstream of RDE-4 (103). Thus, we expected to see enhanced viral replication in rsd-2;rde-1 
double mutants compared to rde-1 single mutants if rsd-2 indeed contributes to RDVI in an rde-
4-independent manner. As shown in Figure 5.2 panel B&C, right panel, enhanced viral 
replication, although to a lesser extent, was observed in rsd-2;rde-1 double mutants compared to 
rde-1 single mutants. As expected, FR1gfp-derived siRNAs accumulated in rsd-2;rde-1 double 
mutants (Figure 5.2 panel A, lane 1). Taken together, these results strongly suggest that there is 





Figure 5.2 rsd-2 contributes to rde-4-independent antiviral silencing. A. Accumulation of 
FR1gfp-derived siRNAs in double mutants, as indicated, defective in RDVI. See Figure 5.1 
panel E for experimental details. B.  Accumulation of Orsay virus RNA1 (ovRNA1) in wild type 
N2 worms and RDVI defective mutants carrying single or double mutations as indicated. See 
Figure 5.1 panel B for experimental details. C. Accumulation of FR1gfp transcripts in various 
genetic backgrounds as indicated. See Figure 5.1 panel A for experimental details. 
5.4 rsd-2 and rrf-1 function in the same RDVI pathways 
            rrf-1 encodes an RdRP that initiates de novo synthesis of secondary siRNAs using the 
targeted transcript as template in RNAi (101, 102, 116, 129). To find out whether rsd-2 functions 
in the same genetic pathway as rrf-1, which is known to function downstream of rde-4 and rde-1 
(103, 104), we checked viral replication in rsd-2;rrf-1 double mutant as compared to the single 
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mutants. We expected to see enhanced viral replication in the double mutants if rsd-2 and rrf-1 
function in separate genetic pathways. However, as shown in Figure 5.3 panel A, an 
enhancement in the replication of FR1gfp or Orsay virus was not observed in the double mutants 
compared to the single mutants (compare lane 4 with lanes 2 and 3 in the left panel and lane 5 
with lanes 3 and 4 in the right panel). Consistently, FR1gfp-derived 23-nt primary siRNAs 
accumulated to comparable levels in the rsd-2;rrf-1 double mutants and in the single mutants 
(Figure 5.3 panel B, compare lanes 1 and 2 with lane 7). This result, together with the results 
shown in Figure 5.2, suggests that both rrf-1 and rsd-2 function in two independent genetic 
pathways that mediate rde-4-dependent and rde-4-independent antiviral silencing respectively. 
 
Figure 5.3 rsd-2 and rrf-1 function in the same antiviral silencing pathways. A. Left panel: 
accumulation of FR1gfp transcripts in various genetic backgrounds as indicated. See Figure 5.1 
panel A for experimental details. Right panel: accumulation of Orsay virus in single or double 
mutants containing rsd-2 and/or rrf-1 null alleles. C. The accumulation of FR1gfp-derived 
siRNAs in single or double mutants containing rsd-2 and/or rrf-1 null alleles. See Figure 5.1 
panel E for experimental details. 
5.5 rrf-1 contributes to rde-4-independent antiviral silencing  
          To confirm that rrf-1 indeed contributes to rde-4-independent RDVI, we first compared 




Figure 5.4 rrf-1 contributes to rde-4-independent antiviral silencing. A. Accumulation of Orsay 
virus RNA1 (ovRNA1) in wild type N2 worms and RDVI defective mutants carrying single or 
double mutations as indicated. B. Accumulation of FR1gfp transcripts in wild type N2 worms 
and RDVI defective mutants carrying single or double mutations as indicated. C. Accumulation 
of FR1gfp-derived siRNAs in double mutants, as indicated, defective in RDVI in the single 
mutants corresponding to rrf-1, drh-1 and rde-4.  
that in the single mutants corresponding to rrf-1, drh-1 and rde-4. We expected to see enhanced 
viral replication in the double mutants if rrf-1 indeed contributes to rde-4-independnet RDVI. As 
shown in Figure 5.4 panel A&B, both FR1gfp and Orsay virus replicated to higher levels in the 
double mutants compared to the single mutants. Most importantly, we detected FR1gfp-derived 
primary siRNAs in the rrf-1;rde-4 and rrf-1;drh-1 double mutants in contrast to that in drh-
1;rde-4 double mutants (Figure 5.4 panel C, compare lanes 2 and 4 with lane 2). As shown in 
Figure 5.4 panel A&B, an increase in FR1gfp replication was observed in the rrf-1;rde-1 double 
mutants as compared to the single mutants although such an increase was not clear for Orsay 
virus. As expected, FR1gfp-derived primary siRNAs also accumulated in rde-1;rrf-1 double 
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mutants (Figure 5.4 panel C, lane 3). These observations thus confirmed that rrf-1 plays a role in 
RDE-4-independnet RDVI. 
5.6 rde-1 plays a role in rde-4-independent RDVI  
           Previously, an enhanced viral replication was observed in drh-1;rde-1, but not in drh-
1;rde-4, double mutants compared to the single mutants (62), suggesting a role for rde-1 in rde-
4-independent RDVI. To find out whether rde-1 indeed contributes to rde-4-independent RDVI, 
we compared both viral replication and primary viRNA accumulation in rde-1;rde-4 double 
mutants and the single mutants. We expected to see enhanced viral replication and accumulation 
of primary viRNAs if rde-1 indeed plays a role in rde-4-independent RDVI. As shown in Figure 
5.5 panel A, both Orsay virus and FR1gfp replicated to higher levels in the double mutants 
compared to the single mutants. Most importantly, FR1gfp-derived primary siRNAs, although 
not detectable in the drh-1;rde-4 double mutants, became readily detected the in rde-1;rde-4 
double mutants (Figure 5.5 panel B, compare lane 3 with lane 2). These results together 
suggested that rde-1 also plays a role in rde-4-independent RDVI.  
 
Figure 5.5 rde-1 contributes to rde-4-independent antiviral silencing. A. Viral replication is 
further enhanced in rde-1;rde-4 double mutants compared to the single mutants. Shown here is 
the accumulation of Orsay virus (left panel) and FR1gfp transcripts in single or double mutants 
containing rde-1 and/or rde-4 null alleles. B. Accumulation of FR1gfp-derived primary siRNAs 




5.7 sid-1 is not required for RDVI targeting Orsay virus 
           In C. elegans, RNAi triggered by artificial long dsRNA spreads systemically and causes 
sequence-specific silencing in distant tissues that are not exposed to the dsRNA trigger (1).  This 
observation raised a question whether, like that in plants (28, 29), worm RDVI involves an 
intercellular signal that prevents viruses from spreading systemically. Previously, we have shown 
that RDVI triggered by an FHV replicon was not compromised in sid-1 mutants (105) defective 
in RNAi spreading (65, 68, 130). However, since potent RDVI will have been triggered in every 
single cells that contain the replicon transgene a systemic silencing signal may not be needed to 
silence such a viral replicon that is not known to move systemically. To find out whether worm 
RDVI indeed spreads systemically to restrict virus spread under natural condition, we compared 
Orsay virus infection in between wild type N2 worms and worms defective in sid-1. As shown in 
Figure 5.6, an increase in Orsay virus replication was not detected in sid-1 mutants as compared 
to that in wild type N2 worms (compare lane 4 with lane 2). Based on this observation, we 
concluded that sid-1 mediated systemic RNAi is not required for restricting Orsay virus infection 
in C. elegans.  
 
Figure 5.6 sid-1 is not required for RDVI in C. elegans. Shown here is the accumulation of Orsay 






Figure 5.7 A working model for rde-4-dependent and rde-4-independent antiviral silencing in C. 
elgans. WAGO, worm-specific AGO (103). Here we propose that the processing of viral 
dsRNAs into primary viRNAs occurs in rde-4-dependent or rde-4-independent manner. drh-1 
contributes to the rde-4-dependent, but not rde-4-independent, antiviral  silencing. We believe 
that rsd-2 and rrf-1 contribute to both rde-4-dependent and rde-4-independent antiviral silencing 
while rde-1 plays a major function in the rde-4-dependent antiviral silencing and a minor 
function in rde-4-independent antiviral silencing. We also believe that the major function of  rrf-
1 is to direct the synthesis of secondary viRNAs, rsd-2 contributes to the function of primary 
viRNAs, thereby initiating the synthesis of secondary viRNAs. As proposed previously, some 
WAGOs may direct the cleavage of cognate viral transcripts using the secondary viRNAs as 
sequence guide (103). 
5.8 Conclusions 
In this chapter, I first established an antiviral role of RSD-2 by showing that rsd-2 null 
mutants (tm1429 and pk3307) permitted higher levels of viral RNA accumulation, and that this 
enhanced viral susceptibility was reversed by ectopic expression of wild type RSD-2 open 
reading frame. I then examined the relationship of rsd-2 with other known components of RNAi 
pathways and established that rsd-2 functions in a novel pathway that is independent of rde-4 but 
likely requires the RNA-dependent RNA polymerase RRF-1, suggesting a critical role for RSD-2 
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in secondary viRNA biogenesis, likely through coordinated action with RRF-1. Together these 
results suggest that RDVI in the single-Dicer organism C. elegans depends on the collective 
actions of both RDE-4-dependent and RDE-4-independent mechanisms to produce RNAi-
inducing viRNAs. My study reveals, for the first time, a novel siRNA-producing mechanism in 




CHAPTER 6 HOMOLOGOUS RIG-I-LIKE HELICASE PROTEINS 
DIRECT RNAI-MEDIATED ANTIVIRAL IMMUNITY IN C. ELEGANS BY 
DISTINCT MECHANISMS1 
6.1 Introduction 
In the previous chapter, I described that the worm-specific gene rsd-2 plays an essential 
role in RNAi-directed viral immunity (RDVI) in Caenorhabditis elegans. In this chapter I will 
focus on another worm-specific RDVI component, termed Dicer-related helicase 1 (DRH-1), 
which encodes the helicase and C-terminal regulatory domains homologous to the mammalian 
RIG-I-like helicase (RLH) family of cytosolic immune receptors. Previous studies through small 
RNA analysis indicated that DRH-1 contributes to RDVI in the RDE-4 (a double stranded RNA 
binding protein) dependent pathway. However, how DRH-1 regulates the ancient antiviral innate 
immunity through RNAi remains largely unknown. Interestingly, C. elegans DRH family include 
two additional members, named DRH-2 and DRH-3. DRH-2, a close homologue of DRH-1, 
seems to be a negative regulator of RDVI, but the molecular and biochemical mechanism of 
DRH-2 in RDVI remains to be defined. DRH-3, which shares a more divergent sequence 
homologue with DRH-1 and DRH-2, is known to be required for worm development and 
contribute to classic RNAi, including germline RNAi. Currently, whether DRH-3 also plays a 
role in RDVI is unknown. To address these questions, I first developed a DRH-1 function rescue 
assay that would allow me to determine the requirement of each of DRH-1 domain in RDVI. 
Using this assay, I found that the helicase domain and C-terminal regulatory domain (CTD) of 
DRH-1 can be independently replaced by the corresponding RIG-I domains known to contribute 
to virus sensing, suggesting a role of DRH-1 in virus detection. I further showed that DRH-2 
                                                 
1 “Part of this chapter previously appeared as [Guo X, Zhang R, Wang J, Ding SW and Lu R, 
Homologous RIG-I-like helicase proteins direct RNAi-mediated antiviral immunity in C. elegans 




may negatively regulate RDVI by acting as a competitor of DRH-1 and DRH-3 functions 
downstream of primary, but upstream of secondary siRNA, biogenesis in worm RDVI.  
6.2 DRH-1 is required for nematode defense against infection by a natural virus pathogen  
An antiviral role of DRH-1 was first identified through the characterization of antiviral 
RNAi induced by replication of FHV, which does not naturally infect C. elegans (62). A recent 
report described identification of a natural C. elegans virus, Orsay virus, which is closely related 
to FHV and shown to accumulate to significantly enhanced levels in RNAi-defective worm 
mutants such as rde-1 and rde-4 (50). We found that Orsay virus infection was also markedly 
enhanced in worm mutants carrying either of the two drh-1 loss-of-function alleles (Fig. 6.1 
panel A). This finding indicates that DRH-1 is also required for natural antiviral defense in C. 
elegans.  
        To verify the antiviral RNAi function of DRH-1, we carried out a transgene 
complementation assay in drh-1 mutant animals as illustrated in Figure 6.2 panel A. In this assay, 
plasmid Psur-5::DRH-1 that directed DRH-1 expression under the constitutively active sur-5 
promoter was injected into drh-1 mutant animals that carried the chromosomally integrated 
transgene FR1gfp controlled by a heat-inducible promoter (62). Heat treatment of drh-1;FR1gfp 
worms is expected to induce replication of the FHV-based RNA replicon and expression of the 
replicon-encoded green fluorescence protein (GFP) from a subgenomic mRNA synthesized by 
the FHV replicase. Since FR1gfp does not encode the RNAi suppressor protein B2 (62) green 
fluorescence would be undetectable if antiviral RNAi is restored in drh-1 mutant animals by 
ectopic expression of DRH-1. We found that green fluorescence indeed became undetectable in 
drh-1;FR1gfp worms following gonad microinjection with Psur-5::DRH-1 (compare animals 
carrying Psur-5::DRH-1 marked by the red fluorescence expressed from the co-injected mCherry 
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reporter plasmid with animals showing no red fluorescence in heads, Fig. 6.2 panel B). This 
finding illustrated that ectopic expression of DRH-1 restored antiviral RNAi in the drh-1 mutants.  
 
 
Figure 6.1 Both the N- and C-terminal domains of DRH-1 are indispensable for antiviral RNAi. 
A. Accumulation of Orsay virus RNA1 detected by Northern blot in wild type worms and 
genetic mutants as indicated. N2, the Bristol isolate of wild type C. elegans. JU1580, an isolate 
of C. elegans that is defective in antiviral RNAi. Methylene blue-stained ribosomal RNA (rRNA) 
serves as equal loading control. B. Schematic structure of DRH-1 and its derivatives used in the 
DRH-1 function rescue assay. NTD, N-terminal domain. DExD/H, the DEAD-box superfamily 
domain. Helicase C, the RNA helicase superfamily C terminal domain. CTD, C-terminal 
regulatory domain originally identified in RIG-I. C. Northern blot detection of FR1gfp 
transcripts in drh-1 mutants carrying the integrated transgenes corresponding wild type DRH-1 
or its derivatives as indicated 48 hours post heat induction. Methylene blue stained ribosomal 
RNA serves as equal loading control. D. Orsay virus RNA1 detected by Northern blot in drh-1 
mutants carrying the integrated transgenes corresponding wild type DRH-1 or its derivatives as 
indicated 72 hours post virus inoculation. 
      To further confirm this result, drh-1;FR1gfp worms carrying a stably integrated Psur-
5::DRH-1 transgene were generated and used for the heat induction of FR1gfp or for Orsay virus 
infection. Northern blotting analysis showed that FR1gfp replication and Orsay virus infection 
were both suppressed in drh-1 mutants containing the Psur-5::DRH-1 transgene (Fig. 6.1 panel 
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C/D). These results together show that DRH-1 plays an essential role in the worm antiviral RNAi 
induced by either FHV replication or Orsay virus infection.  
6.3 Both the N- and C-terminal domains of DRH-1 are indispensable for antiviral RNAi  
           The DRH-1 function rescue assay established above made it possible for us to map the 
domain requirement in the antiviral function of DRH-1. In addition to the DEAD-box RNA 
helicase domain, DRH-1 contains a worm-specific N-terminal domain (NTD) and a conserved 
C-terminal regulatory domain (CTD) originally identified in RIG-I (131). We generated four 
domain deletion mutants of DRH-1 (Fig. 6.1 panel B), named DRH-1NTD, DRH-1DHC, DRH-
1NDH and DRH-1NDHp respectively, and examined their antiviral activity using the DRH-1 
function rescue assay. We found that ectopic expression of none of these four DRH-1 mutants 
restored antiviral RNAi in drh-1;FR1gfp worms (Fig. 6.2 panel B), indicating that both of the 
terminal domains of DRH-1 are essential for its antiviral function. As a further confirmation, we 
generated chromosomal integrants carrying nuclear transgenes corresponding to each of these 
DRH-1 deletion mutants and assayed for both FR1gfp replication and Orsay virus infection in 
the selected animal lines. Northern blot analysis (Fig. 6.1 panel C&D) showed that neither 
FR1gfp replication nor Orsay virus infection was suppressed in integrants carrying any of the 
DRH-1 domain deletion mutants, in contrast to the control integrants carrying the wild type 
DRH-1 transgene. Western blotting suggested stable expression of both DRH-1NTD and DRH-
1NDH examined in transgenic worms by C-terminal tagging with an HA epitope (Fig. 6.2 panel 
C&D). These results together indicate that, in addition to the central helicase domains, both NTD 





Figure 6.2 Both the N- and C-terminal domains of DRH-1 are indispensable for antiviral RNAi. 
A. Upper panel, schematic structure of the plasmid constructs Psur-5::DRH-1 and Pmyo-
2::mCherry. Psur-5, the promoter of the endogenous gene sur-5. Pmyo-2, the promoter for the 
endogenous gene myo-2. UTR, the 3’ end untranslated region of the endogenous gene unc-54. 
Lower panel, schematic strategy of DRH-1 function rescue assay. Red dots indicate red 
fluorescence in the pharynx tissue. Green color represents green fluorescence produced by 
replicative FR1gfp. B. Visualization of green fluorescence in drh-1 mutants (tm1329) carrying 
the FR1gfp replicon transgene and the extrachromosmal arrays corresponding to wild type DRH-
1 or its derivatives, as indicated. Expression of mCherry in pharynx tissue directed by the myo-2 
promoter serves as visual mark of the transgenes. C. and D. Western blot detection of HA-tagged 
DRH-1 and its derivatives in corresponding transgenic worms. M, molecular weight references. 
1, non-transgenic N2 worms. 2, N2 worms transgenic for HA-tagged DRH-1 or its derivatives as 
indicated. NTD-HA, HA-tagged DRH-1NTD. NDH-HA, HA-tagged DRH-1NDH. The 
expression of β-actin was detected and used as equal loading controls. 
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6.4 The predicted domains of DRH-2 were functional in a fusion protein with the N-
terminal domain of DRH-1 
         The predicted DRH-2 protein is highly homologous to DRH-1 (Fig. 6.3) but lacks the 
worm-specific NTD plus one of the three motifs in the DEAD-box helicase domain. We 
determined if use of the predicted protein domains of DRH-2 to replace the corresponding 
domains of DRH-1 produced a chimeric protein capable of mediating antiviral RNAi in drh-1 
mutant background. We found that ectopic expression of such a chimeric protein, D1D2 (Fig. 6.4 
panel A), was associated with loss of GFP expression in drh-1;FR1gfp worms (Fig. 6.5 panel A), 
indicating rescue of DRH-1 function in antiviral RNAi by D1D2 driven by the constitutive sur-5 
promoter. We next generated stable animal lines expressing D1D2 driven by either sur-5 or the 
heat-inducible promoter in drh-1;FR1gfp background. Northern blot analysis showed that 
expression of D1D2 driven by the sur-5 promoter suppressed the replication of both FR1gfp and 
Orsay virus in the drh-1 mutant background (Fig. 6.4 panel B&C). Notably, expression of D1D2 
utilizing the heat inducible promoter conferred stronger antiviral RNAi targeting FR1gfp 
replicon (Fig. 6.4 panel B). However, transgenic expression of DRH-2, the region of DRH-1 
equivalent to DRH-2 (DRH-1DHC*), or the N-terminal region of DRH-1 absent in DRH-2 
(DRH-1NTD*), was insufficient to rescue DRH-1 function (Fig. 6.4 panel A&B&C/Fig 6.5 
panel A). Epitope-tagging and Western blotting assay suggested stable expression of DRH-
1NTD*, DRH-1DHC* and DRH-1 in transgenic worms (Fig. 6.5 panel B). Thus, these findings 
indicate that when expressed as a fusion protein with the NTD of DRH-1, the predicted helicase 
and CTD domains of DRH-2 mediate antiviral RNAi as effectively as the corresponding 




Figure 6.3 DRH-1 and DRH-2 share high-level sequence homology. Shown here is the sequence 
alignment between DRH-2 and DRH-1as generated by Clustal W. Sequence marked with red 
box represents the conserved DEAD-box domain. Sequence marked with green box represents 
the conserved helicase C terminal. Sequence marked with blue box represents the conserved C-




Figure 6.4 The putative domains encoded by DRH-2 mediate antiviral RNAi when fused with 
the NTD of DRH-1. A. Schematic structure of DRH-1, DRH-2 and their domain variants. See 
Figure 6.1 panel B and main text for more details. B. Accumulation of FR1gfp transcripts 
detected by Northern blot in drh-1 mutant carrying the integrated transgenes corresponding to 
wild type DRH-1, putative DRH-2 or their domain variants as indicated. HI denotes DRH-1 
function rescue utilizing heat inducible promoter for candidate gene expression. C. 
Accumulation of Orsay virus RNA1 detected by Northern blot in drh-1 mutants carrying the 
integrated transgenes corresponding to wild type DRH-1, putative DRH-2 or their domain 
variants as indicated. OK3495, a DRH-1 variant encoded by the ok3495 allele.  
6.5 The helicase and CTD domains of RIG-I were functional in a fusion protein with the N-
terminal domain of DRH-1 
         An essential role for both the N- and C-terminal domains of DRH-1 in the antiviral defense 
is analogous to the domain requirement of mammalian RIG-I (132). DRH-1 shares significant 
sequence homology in the RNA helicase and CTD domains with RIG-I (Fig. 6.6) although by 
comparison DRH-1 and RIG-I are more distantly related than between DRH-1 and DRH-2. We 
found that transgenic expression of human RIG-I or a truncation mutant removing the N-terminal 
CARD domains (RIG-IDHC) in drh-1;FR1gfp worms did not suppress replication of FR1gfp 
(Fig. 6.7 panel A/6.8 panel A). Since the worm-specific NTD of DRH-1 was indispensable in 
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antiviral RNAi, we next determined the antiviral activity of a DRH-1/RIG-I chimeric protein 
termed D1RIG-I, in which the N-terminal CARD domains of human RIG-I were replaced with 
the NTD of DRH-1 (Fig. 6.7 panel A). As shown in Figure 6.7 panel A, ectopic expression of 
D1RIG-I, but not D1RIG-IND, effectively restored antiviral RNAi in drh-1;FR1gfp worms, 
indicating that the helicase and CTD domains of RIG-I confer similar biological function as the 
corresponding DRH-1 domains do. Similarly, antiviral RNAi was also restored by another DRH-
1/RIG-I chimeric protein, D1RIG-ID1C, in which only the central helicase domain of DRH-1 
was replaced by the corresponding domain of RIG-I (Fig. 6.7 panel A/6.8 panel A). This finding 
showed that antiviral RNAi was mediated by the helicase domain of RIG-I in the context of the 
N- and C-terminal domains of DRH-1. 
 
Figure 6.5 The predicted domains of DRH-2 were functional in a fusion protein with the N-
terminal domain of DRH-1. A. Visualization of green fluorescence in drh-1 mutants (tm1329) 
carrying both FR1gfp nuclear transgene and extrachromosmal arrays corresponding to wild type 
DRH-1, putative DRH-2 or their domain variants as indicated. See Figure S1B for experimental 
details. B. Western blot detection of HA-tagged DRH-1, DRH-1NTD* and DRH-1DHC* in 
transgenic worms generated through co-injection of three plasmid constructs corresponding to 
HA-tagged DRH-1, DRH-1DHC* and DRH-1NTD* respectively. M, molecular weight 
references. 1, non-transgenic N2 worms. 2, N2 worms transgenic for HA-tagged DRH-1, DRH-
1NTD* and DRH-1DHC*. DRH-1-HA, HA-tagged DRH-1. DHC*-HA, HA-tagged DRH-
1DHC*. NTD*-HA, HA-tagged DRH-1NTD*. The expression of β-actin was detected and used 




Figure 6.6 DRH-1 and RIG-I share significant sequence homology within the RNA helicase 
domain, including the DEAD-box subdomain and the helicase C-terminal subdomain, and the 
CTD domain. Shown here is the sequence alignment between DRH-1 and RIG-I as generated by 
Clustal W. Sequence marked with red box represents the conserved DEAD-box domain. 
Sequence marked with green box represents the conserved helicase C terminal. Sequence marked 
with blue box represents the conserved C-terminal regulatory domain of RIG-I.  
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        As described above, we further generated stable animal lines carrying each of these DRH-
1/RIG-I chimeric constructs and assayed for both FR1gfp replication and Orsay virus infection in 
the selected animal lines. Consistent with the above observations, replication of both FR1gfp and 
Orsay virus was significantly inhibited in stable transgenic animals constitutively expressing 
D1RIG-I and heat inducible expression of D1RIG-ID1C restored antiviral RNAi to an extent 
comparable to that by D1RIG-I (Fig. 6.7 panel B/C/D). As observed above for D1D2, the heat 
inducible promoter directed more efficient rescue on DRH-1 function in antiviral FR1gfp 
silencing than the constitutive promoter (Fig. 6.7 panel B). These results together indicated that 
either of the RNA helicase and CTD domains of RIG-I is competent to functionally replace the 
homologous domain of DRH-1 in antiviral RNAi in C. elegans. 
        Previous structural studies showed that a KWK motif in the CTD of RIG-I mediates 
physical interaction between RIG-I and dsRNA although it is unknown if the interaction is 
functionally important (84, 85, 133). Since the KWK motif is conserved in DRH-1 CTD (Fig. 6.8 
panel B upper panel), we next determined if this motif is critical for antiviral RNAi in C. elegans. 
To this end, we introduced the alanine substitutions into the KWK motif in the CTD domains of 
both DRH-1 and D1RIG-I, and subjected the resulting mutant constructs, DRH-1AAA and 
D1RIG-IAAA, to DRH-1 function rescue assay. As shown in Figure 6.8 panel B lower panel and 
Figure 6.8 panel C, expression of either mutant was unable to restore DRH-1 function in antiviral 
RNAi against FR1gfp. These findings strongly suggest that antiviral RNAi mediated by DRH-1 
involves an essential activity of DRH-1 to detect viral dsRNA in a manner analogous to virus 





Figure 6.7 The RNA helicase and CTD domains of RIG-I functionally replace the corresponding 
domains of DRH-1 in antiviral RNAi. A. Schematic structure of RIG-I and its domain variants. B. 
Accumulation of FR1gfp transcripts detected by Northern blot  in drh-1 mutants carrying the 
integrated transgenes corresponding to wild type DRH-1 or RIG-I domain variants as indicated. 
HI denotes DRH-1 function rescue utilizing heat inducible promoter for candidate gene 
expression. C. Accumulation of Orsay virus RNA1 detected by Northern blot  in drh-1 mutants 
carrying the integrated transgenes corresponding wild type DRH-1 and D1RIG-I. D. 
Accumulation of FR1gfp transcripts detected by Northern blot  in drh-1 mutants carrying the 
integrated transgenes corresponding wild type DRH-1, D1RIG-I and D1RIG-ID1C.  
6.6 DRH-3 regulates antiviral RNAi by a mechanism distinct from DRH-1  
        DRH-3 shares a similar domain structure with DRH-1 but contains more divergent 
sequences compared to DRH-1 and DRH-2 (Fig. 6.9). Recent studies have shown that DRH-3 is 
required for germline development and RNAi by participating in the biogenesis of 22G RNAs 




Figure 6.8 The helicase and CTD domains of RIG-I were functional in a fusion protein with the 
N-terminal domain of DRH-1. A. Visualization of green fluorescence in drh-1 mutants carrying 
both FR1gfp replicon transgene and extrachromosmal arrays corresponding to wild type RIG-I or 
its domain variants, as indicated. See Figure 6.1 C for experimental details. B. Upper panel, 
sequence alignment between the C-terminal sequences of DRH-1 and RIG-I. The KWK motifs 
are highlighted with bold fonts. Lower panel, visualization of green fluorescence in drh-1 null 
mutants (tm1329) carrying both FR1gfp replicon transgene and extrachromosmal arrays 
corresponding to DRH-1AAA or D1RIG-IAAA. DRH-1AAA, a DRH-1 variant that contains 
K988A, W989A and K990A point mutations. D1RIG-IAAA, a D1RIG-I variant that contains the 
K982A, W983A and K984A point mutations.  C. Accumulation of FR1gfp transcripts detected 
by Northern blot in drh-1 mutants carrying heat inducible transgenes corresponding to DRH-
1AAA or D1RIG-IAAA.  
replication and Orsay virus infection in worms containing the ne4253 allele of drh-3. A single 
amino acid change occurred in the helicase C domain of DRH-3 encoded by the ne4253 allele 
and, as a result, worms containing this allele are defective in dsRNA-induced RNAi in the 
somatic tissues (136). We found that drh-3 mutant worms were highly susceptible to Orsay virus 
infection (Fig. 6.10 panel A, top). Northern blot analysis detected similarly high level replication 
of Orsay virus in drh-3, drh-1 and JU1580 mutant worms. Moreover, we found that FR1gfp also 
replicated to higher levels in drh-3 mutant worms compared to wild type N2 worms (Fig. 6.10 
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panel A, bottom). These findings indicate that DRH-3 indeed plays a role in worm antiviral 
RNAi.  
To define a role for DRH-3 in antiviral RNAi, we compared the accumulation of FR1gfp-
derived viral siRNAs in drh-1 and drh-3 mutants using control mutants known to be defective in 
the biogenesis of primary siRNAs (rde-4) or secondary siRNAs (rde-1 and rrf-1) (92, 103, 115). 
Consistent with previous deep sequencing results (115, 128), several species of viral siRNAs 
were detected in the rde-1 mutants with a major band detected at the position corresponding to 
23 nucleotides (nt) (Fig. 6.10 panel B). Viral siRNAs also accumulated to readily detectable 
levels in both drh-3 and rrf-1 mutants with a dominant 23-nt band similar to that in rde-1 
mutants (Fig. 6.10 panel B/6.11), indicating robust production of viral primary siRNAs in drh-3, 
rde-1, and rrf-1 mutants. By comparison, viral siRNAs including the 23-nt species reproducibly 
accumulated to much lower levels in both drh-1 and rde-4 mutants than in rde-1 and drh-3 
mutants even though the FR1gfp replicated to comparable levels in rde-1, drh-1 and drh-3 
mutants (Fig. 6.10 panel A&B/6.11).  
        Our findings suggested a major defect of drh-1 mutant animals in the biogenesis of primary 
viral siRNAs as in rde-4 mutant animals. In contrast, loss of antiviral RNAi in drh-3 mutant 
animals was not associated with defective biogenesis of viral primary siRNAs, suggesting that 
DRH-3 may regulate the biogenesis of viral secondary siRNAs as demonstrated for its role in 
exogenous RNAi (136). To test this idea, we compared the viral siRNA profiles in drh-3 and rrf-
1 mutant animals through deep sequencing using a cloning protocol capturing both primary and 
secondary siRNAs. As found in studies on exogenous RNAi (92, 103, 115), rrf-1 mutant animals 
produced a typical population of primary siRNAs since the sequenced viral siRNAs were 
predominantly 23 nucleotides in length, contained similar reads number for positive and negative  
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strands, and were not enriched for 22-nt siRNAs with 5’-terminal guanine nucleotide (Fig. 6.10 
panel C, left). We found that the profile of viral siRNAs sequenced from drh-3 mutant animals 
  
Figure 6.9 DRH-3 contains more divergent sequences compared to DRH-1 and DRH-2. Shown 
here is the sequence comparison in between DRH-1, DRH-2 and DRH-3.  Clustal W was used 
for the sequence alignment. 
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 (Fig. 6.10 panel C, right) were highly similar to that from rrf-1 mutant animals and lacked a 
population of 22G RNAs. These observations together suggested a role for DRH-3 in the 
biogenesis of viral secondary siRNAs. 
 
 
Figure 6.10 DRH-3 regulates antiviral RNAi by a mechanism distinct from DRH-1. A. Upper 
panel, accumulation of Orsay virus RNA1 detected by Northern blot in JU1580, wild type N2 
worms and genetic mutants defective in drh-3 or drh-1 as indicated. Lower panel, accumulation 
of FR1gfp transcripts detected by Northern blot in wild type N2 worms and genetic mutants 
defective in drh-3, rde-1 or drh-1 as indicated. B. Accumulation of FR1gfp-derived siRNAs 
detected by Northern blot in different genetic backgrounds as indicated. Shorter exposure image 
of the same blot is shown in the lower panel. C. Primary and secondary FR1gfp-derived siRNA 
populations in rrf-1 and drh-3 mutants. The reads are grouped based on polarity and according to 




Figure 6.11 DRH-3 regulates antiviral RNAi by a mechanism distinct from DRH-1. Left panel, 
accumulation of FR1gfp transcripts detected by Northern blot in wild type N2 worms and genetic 
mutants defective in drh-1, rrf-1 or drh-3. Right panel, accumulation of FR1gfp-derived siRNAs 
detected by Northern blot in rrf-1 and drh-3 mutants. The accumulation of miR-58 was detected 
by Northern blot and used as both size reference and equal loading control. 
6.7 DRH-1 is dispensable for RNAi targeting cellular transcripts 
           In contrast to antiviral RNAi, DRH-1 is largely dispensable in RNAi induced artificially 
to target cellular transcripts of endogenous genes such as skn-1, dpy-13 and unc-22 (62) or 
transgene (Fig. 6.12). Our recent study has detected RNAi of cellular mRNAs targeted by virus-
derived siRNAs in C. elegans (105). Since low levels of FR1gfp-derived viral siRNAs remained 
detectable in drh-1 mutants (Fig. 6.10 panel B), we next determined if these viral siRNAs were 
active in RNAi targeting cellular transcripts in the absence of DRH-1. To test this hypothesis, we 
utilized a transgenic worm strain carrying a Psur-5::GFP transgene and a previously described 
replicon transgene, FR1fp, which does not express GFP due to deletion of the 5’-half of the GFP 
coding sequence but triggers potent silencing of the homologous cellular GFP transcripts (105) 
(Fig. 6.13 panel A). As expected, FR1fp replication triggered potent gfp silencing, manifested as 
reduction in the intensity of green fluorescence in the wild type N2 worms, but not in RNAi 
defective mutants corresponding to rde-1 or rde-4 (Fig. 6.13 panel B). Consistently, FR1fp-
derived siRNAs accumulated at lower levels in drh-1 mutants than in rde-1 mutants (Fig. 6.14 
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panel A). We detected gfp silencing also in drh-1 mutants albeit to a lesser extent (Fig. 6.13 
panel B). Northern blot analysis showed that the gfp transcripts were markedly reduced in wild 
type N2 worms and drh-1 mutants but not in drh-1 double mutants with rde-1 or rde-4 (Fig. 6.14 
panel B). In contrast, both RNAs 1 and 3 from replicon FR1fp accumulated to high levels in all 
of the examined drh-1, rde-1, and rde-4 single and double mutants (Fig. 6.14 panel B). These 
findings showed that drh-1 was essential for silencing a replicating viral replicon, but not a 
homologous cellular mRNA targeted by the same pool of siRNAs in the same animals. In an 
independent set of experiments, we compared the susceptibility of the replicating FR1fp and 
cellular GFP mRNA to feeding RNAi and found that cellular transcripts remained highly 
susceptible unlike the viral replicon (Fig. 6.15).  Therefore, we propose that unlike drh-3 that is 
required for both exogenous RNAi and antiviral RNAi, participation of an additional drh-1 
pathway is necessary to inhibit virus infection.   
 
Figure 6.12 DRH-1 is not required for long dsRNA triggered RNAi. A. Structure of the Psur-
5::GFP transgene. Psur-5, the promoter of the worm gene sur-5. GFP, the coding sequence of 
enhanced green fluorescent protein. UTR, the 3’ end untranslated region of the worm gene unc-
54. B. Northern blot detection of gfp transcripts in response to gfp dsRNA ingestion in different 
worm strains as indicated. The accumulation of gfp transcripts was detected at 0 hour (left panel) 
and 48 hours (right panel) after gfp dsRNA ingestion as indicated. The full length gfp cDNA was 
used to prepare probes for hybridization. Methylene blue-stained ribosomal RNA serves as equal 




Figure 6.13 DRH-1 is dispensable for RNAi targeting cellular transcripts. A. Schematic of 
experiment strategy used to test whether DRH-1 is required for the silencing of cellular 
transcripts mediated by viral siRNAs. HIP, heat inducible promoter. Protein A, the replicase of 
FHV. FP, the 3’ end half of GFP coding sequence. Rz, self-cleaving ribozyme sequence derived 
from hepatitis D virus, which functions to remove all non-viral sequence at the 3’ end of the 
FR1fp primary transcripts. B. Visualization of gfp silencing triggered by replicating FR1fp in 
different genetic backgrounds as indicated. All worm strains carry the same Psur-5::GFP 
transgene and FR1fp replicon transgene which uses mCherry expressed in pharynx as visual 
mark. 
 
Figure 6.14 DRH-1 is not required for the silencing of cellular transcripts mediated by viral 
siRNAs. A. Accumulation of FR1fp-derived siRNAs detected by Northern blot in wild type N2 
worms and genetic mutants defective in rde-1, rde-4 and drh-1 as indicated. B. Northern blot 
detection of GFP silencing triggered by FR1fp replication in different genetic backgrounds as 
indicated 48 hours post heat induction. The GFP transcripts were detected using oligo probes that 




Figure 6.15 Replicating viruses are less sensitive to long dsRNA triggered RNAi compared to 
cellular transcripts. A. Schematic of the strategy used to test whether replicating viruses are less 
sensitive to long dsRNA triggered RNAi compared to cellular transcripts. B. Heterologous 
siRNAs are capable of mediating virus silencing in C. elegans. Transgenic N2 strain carrying the 
Psur-5::GFP and the FR1fp nuclear transgenes was used in this test. Shown here is the 
accumulation of FR1fp transcripts in response to heat induction after the worms have been fed 
on OP50 food or HT115 food expressing gfp dsRNA. Methylene blue strained ribosomal RNA 
serves as equal loading control. C. Accumulation of FR1fp transcripts in response to heat 
induction in worm strains as indicated. All worm strains used in this test contain the same Psur-
5::GFP and FR1fp transgenes as described in B and have been fed on HT115 food expressing the 
gfp dsRNA. The FR1fp transcripts were detected using probes derived from the FP region of 
FR1fp. The GFP transcripts were detected using probes corresponding to the 5’ half of GFP 
coding sequence that does not overlap with the FP region of FR1fp.  
6.8 Conclusions 
Based on the DRH-1 function rescue assay, here I show that ectopic expression of wild 
type DRH-1 suppresses both Flock house virus and Orsay virus replication in drh-1 mutant 
(tm1329) background. The antiviral function of DRH-1 requires the homologous RIG-I domains 
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as well as its worm-specific N-terminal domain (NTD). I also showed that the helicase and C-
terminal domains encoded by either worm DRH-2 or human RIG-I can functionally replace the 
corresponding domains of DRH-1 to mediate antiviral RNAi in C. elegans. Notably, 
substitutions in a three-residue motif (KWK) of the C-terminal regulatory domain (CTD) of 
RIG-I that physically interacts with viral dsRNA abolish the antiviral activity of CTDs of both 
RIG-I and DRH-1 in C. elegans. Genetic analysis revealed an essential role for both DRH-1 and 
DRH-3 in C. elegans antiviral RNAi targeting a natural viral pathogen. However, Northern blot 
and small RNA deep sequencing analyses indicate that DRH-1 acts to enhance production of 
viral primary siRNAs whereas DRH-3 regulates antiviral RNAi by participating in the biogenesis 
of secondary siRNAs after Dicer-dependent production of primary siRNAs. Based on these 
observations, I propose that DRH-1 facilitates the acquisition of viral dsRNA by the worm dicing 
complex for the subsequent processing into primary siRNAs. The strong parallel for the antiviral 
function of RLHs in worms and mammals suggests that detection of viral dsRNA may activate 
completely unrelated effector mechanisms, or alternatively, that the mammalian RLHs have a 
conserved activity to stimulate production of viral siRNAs for antiviral immunity by an RNAi 




CHAPTER 7 DISCUSSION 
7.1 Viral suppression of RDVI in C. elegans 
        RDVI represents a major antiviral mechanism in fungi, plants and insects (20). To survive, 
many viruses produce diverse classes and small proteins, termed VSRs, to suppress RDVI 
through distinct mechanisms (34, 112). Since VSRs can target and suppress RNAi directed by 
endogenous siRNAs and miRNAs, studies on the VSR-mediated virus-host interactions have not 
only significantly improved our understanding of the evolutionary arm race between viruses and 
their natural hosts but also allowed us to gain insight into the mechanistic basis underlying 
disease induction by virus infection in the aforementioned systems (34, 42, 47). The nematode 
worm C. elegans has recently emerged as an important animal model for the study of virus-host 
interaction in single-Dicer invertebrates. So far, the study on VSR-mediated virus-nematode host 
interaction, especially the interaction that leads to disease symptoms, is largely an unexplored 
field mainly owing to the fact that a robust RDVI suppression assay has yet to be developed for 
the identification of VSRs with worm RDVI suppression activity. Here we reported a worm 
RDVI suppression assay system developed using FHV B2 as a reference VSR. Because a viral 
replicon is used as both trigger and target of RDVI, our assay system is expected to identify 
VSRs with true function in RDVI suppression. Using this assay we have successfully identified 
NoV B2, which shares limited sequence homology with FHV B2 but uses similar mechanism in 
RDVI suppression, as another VSR that retains RDVI suppression activity in the worm system, 
confirming the robustness of our assay system. Thus, our assay system for the first time makes it 
possible to identify VSRs with worm RDVI suppression activity. It can be expected that 
functional and mechanistic characterization of VSRs identified using our assay will help unravel 
some unique features of VSR-mediated virus-nematode worm interactions.  
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        Unlike plants and insects, the nematode worm C. elegans uses a single Dicer to initiate both 
RDVI and other RNAi-related pathways. Besides, the worm RDVI pathway features some 
unique components, such as RSD-2 and DRH-1 (62), and is known to require RRF-1, an RdRP 
that produces 22 nt single-stranded secondary siRNAs in a Dicer-independent manner (62, 101, 
102, 116). These observations make it interesting to ask whether the worm RDVI responds 
differently to VSRs identified in heterologous systems. To address this question we assayed the 
RDVI suppression activity for VSRs encoded by fungus, plant and insect viruses in C. elegans. 
Our results clearly showed that, FHV B2 and NoV B2, but not the p19 or 2b proteins encoded by 
plant viruses or the p29 protein encoded fungus virus, suppresses RDVI triggered by replicating 
viruses (Figure 3.1, 3.2, 3.3, 3.4 and data not shown). Interestingly, unlike that in plants and 
insects, FHV B2 appears to target a step downstream of primary siRNA, but upstream of 
secondary siRNA, biogenesis to suppress RNAi (Figure 3.5 panel A & D). These results together 
not only confirmed that worm RDVI indeed responds differently to heterologous VSRs but also 
shed light on some unique mechanistic features of worm RDVI as discussed below. 
         Probably due to a siRNA degradation mechanism (137) the abundance of virus-derived 
siRNAs is extremely low in C. elegans. Using a newly developed Northern blotting protocol 
(105) we managed to detect virus-derived siRNAs at an unprecedented resolution. Consistent 
with previous deep sequencing analysis (115), our Northern blotting analyses detected several 
viral siRNA bands, with the major one detected with a size of 23-nt, in rde-1 mutants (Figure 3.5 
panel A). We believed that these viral siRNAs are bona fide primary siRNA duplexes produced 
by the worm Dicer, considering the facts that the primary siRNAs produced by worm Dicer are 
predominantly 23-nt in size (92), rde-1 mutants are known to accumulate only primary siRNAs 
(103), and the detected viral siRNAs are resistant to Terminator exonuclease, which destroys 
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single-stranded RNA molecules with 5’ end monophosphate group, such as miRNAs, but is 
much less efficient in digesting siRNA duplexes (Figure 3.5 panel D). Our Northern blotting 
analyses also detected an rrf-1-dependent siRNA band with a size falling between 21 and 22nt 
(Figure 3.5 panel A & C). The unique migration pattern of these rrf-1-dependent siRNAs may 
simply reflect the fact that, although 22 nt in size (101, 102, 117), rrf-1-dependent siRNAs carry 
a triphosphate, instead of a monophosphate, group at the 5’ end and thus are expected to migrate 
faster than the 22nt primary siRNAs which carry monophosphate group at the 5’ end.  
         FHV B2 is a versatile VSR that suppresses RNAi in diverse organisms (7, 12, 43). Previous 
biochemical and structural studies suggested that FHV B2 forms homodimers and binds to 
dsRNA without length preference (9, 38, 39). These observations suggested that FHV B2 could 
have dual modes of action in RDVI suppression: inhibiting Dicer-processing of dsRNAs or 
interfering with the function of siRNAs (38). Previously, it has been shown that the major mode 
of action of B2 in plants and insects is to suppress the biogenesis of siRNAs (7, 138). Currently, 
it remains unclear whether FHV B2 actively suppresses RDVI by inhibiting the function of 
siRNAs. Here we show that FR1gfp-derived siRNAs in worms expressing FHV B2 can be 
detected at a comparable amount and with a similar pattern as that in rde-1 mutants (Figure 5 
panel A). Since rde-1 mutant is known to be defective in the biogenesis, but not the function, of 
primary siRNAs (103), this observation suggests that the major mechanism of FHV B2 in worm 
RDVI suppression is to inhibit the function, thus the biogenesis of secondary siRNAs, of primary 
siRNAs. In supporting this notion, the rrf-1-dependent secondary siRNAs became undetectable 
in worms expressing FHV B2 (Figure 3.5 panel A & B). Worm RDVI pathway contains some 
unique components such as DRH-1. Considering the fact that the mammalian counterparts of 
DRH-1 function as cytosolic virus sensors, it is possible that DRH-1 functions as a virus sensor 
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to facilitate the viral dsRNA acquisition by worm Dicer. As a result, the biogenesis of viral 
primary siRNAs can be significantly enhanced even in the presence of FHV B2. However, since 
FHV B2 can inhibit the function of primary siRNAs and the biogenesis of secondary siRNAs, 
the targeted viruses will still be able to replicate efficiently in the presence of FHV B2 as 
revealed in this study.   
          TBSV p19 is a well characterized VSR of plant origin that can suppress RNAi in 
heterologous systems such as insects and mammals (12, 41). Previous studies suggested that both 
TBSV p19 and TAV 2b specifically bind and inhibit the function of 21 nt siRNAs to suppress 
RNAi. Although siRNA duplexes of other sizes can also be bound by these two VSRs, the 
binding affinity diminishes rapidly with increasing size differences (35-37). In fact, because of 
its target specificity TBSV p19 has been used as a universal RNAi suppressor to explore the 
molecular mechanism of 21 nt siRNAs and miRNAs (31, 41). Here we show that, although 
successfully expressed in C. elegans, TBSV p19 failed to suppress long dsRNA triggered RNAi, 
RDVI triggered by two unrelated viruses and the biogenesis of RRF-1-dependent secondary 
siRNAs. This finding suggests that virus-derived 21-nt primary siRNAs, do not make major 
contribution to RDVI in C. elegans (Figure 3.5 panel A&C). 
          In plants, VSRs can interfere with the function of miRNAs, which usually form near-
perfect sequence matches with their passenger strands, resulting in developmental defects or 
diseases (44, 47). Animal miRNAs and their passenger strands often do not form near-perfect 
sequence matches thus have been shown to be resistant to the inhibitory effect of VSRs produced 
in Drosophila (42, 43). Currently, it remains unclear whether VSRs are able to interfere with the 
biogenesis and/or function of miRNAs in the nematode kingdom which uses a single Dicer to 
initiate both siRNA and miRNA pathways. In this report we show that FHV B2 is unable to 
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suppress the biogenesis and function of miRNAs in C. elegans (Figure 3.5&3.6). This is the first 
demonstration that VSRs selectively suppress siRNA, but not miRNA, function in organisms that 
use single Dicer to produce both siRNAs and miRNAs.  
          Previously, endogenous siRNAs that function in transposon control in Drosophila have 
been shown to be susceptible to the inhibitory effect of VSRs (42). Recently, worm endogenous 
siRNAs have been shown to contribute to normal cellular function by maintaining wide-spread 
gene silencing together with piRNAs, a class of endogenous small RNAs whose biogenesis does 
not require Dicer (139). Thus, it was expected that functional inhibition of these endogenous 
siRNAs by nodavirus B2 proteins, which appears to inhibit the function of virus-derived siRNAs 
as shown in Figure 3.5, will induce developmental defects in worms. So far, we have not 
observed any developmental defects associated with constitutive expression of the B2 VSRs. 
However, it remains possible that the inhibitory effect of the B2 proteins on worm endogenous 
siRNAs takes much longer time to develop or needs a specific bioassay to identify. Alternatively, 
strong inhibition of endogenous siRNA function may have resulted in lethal embryos and, as a 
result, only transgenic animals expressing the B2 proteins at low level can survive. In supporting 
this hypothesis, transgenic lines carrying constitutively expressed FHV B2 transgene showed 
weaker Fr1gfp replication rescue compared to those carrying heat inducible FHV B2 transgene 
(Figure 3.2 panel D). Nevertheless, our study suggested that some heterologous VSRs, such as 
the FHV B2, can retain their functional specificity in the worm system, making it possible to use 
these VSRs as genetic tools to study the biogenesis and function of worm endogenous siRNAs.  
7.2 Virus induced gene silencing in C. elegans 
             Viruses are obligate intracellular parasites that absolutely rely on the macromolecule 
synthesis and metabolism pathways of their hosts for replication. Thus, virus-host interaction 
represents one of the most intimate pathogen-host interactions that are tightly regulated by 
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various cellular pathways. RDVI is mediated by one such cellular pathway that is conserved in 
fungi, plants and invertebrates. Previous studies have demonstrated that it is the viRNAs 
processed from the invading viral genomes, in the form of dsRNA, that confer the target 
specificity of RDVI (20). Owing to its sequence-specific nature, RDVI can be redirected to target 
cellular transcripts in plants and in some cases accounts for the induction of plant diseases (57, 
58). Currently, it remains unclear whether viRNAs can guide the silencing of cellular transcripts 
thereby to mediate another layer of virus-host interaction in the animal kingdom. In this report, 
we probed the possibility of VIGS in the nematode worm C. elegans. Our results clearly showed 
that viRNAs can mediate potent silencing of homologous cellular genes, endogenous gene and 
transgene (Figure 4.2 and Figure 4.5). Thus, for the first time, we demonstrated that viRNAs can 
modulate host gene expression in the animal kingdom. Most importantly, the success in 
uncoupling the RDVI trigger and the RDVI target will not only allow us to revisit the virus-
animal host interaction from a new perspective but also facilitate our exploration of the unique 
features of worm RDVI.    
          In plants, VIGS targeting the promoter sequence of a gfp transgene resulted in both 
methylation of the targeted sequence and inheritable transcriptional gene silencing that is 
independent of the virus trigger (140). Interestingly, VIGS targeting the coding region of the 
same gfp transgene resulted in sequence-specific gene silencing and DNA methylation that was 
not inherited. This is in sharp contrast to the VIGS in C. elegans, in which inheritable silencing 
of host genes, endogenous gene and transgene, can be readily triggered when the coding 
sequences were targeted by VIGS. Currently, it remains unclear whether the inheritance of VIGS 
in worm is associated with any epigenetic modifications to the targeted sequences.  
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         Silencing of host genes mediated by virus-derived siRNAs has been shown to be 
responsible for disease induction in plants (57, 58). miRNAs encoded by both DNA and RNA 
viruses can also modulate host gene expression, thereby facilitating virus infection in the animal 
kingdom (59-61). Since miRNAs and siRNAs use similar factors for their biogenesis and 
function, it will be of great interest to see whether viRNAs can modulate host gene expression 
thereby to facilitate virus infection in animal kingdom. Since viRNAs can target and induce 
transgenerational silencing in C. elegans (Figure 4.4&4.5), our study, for the first time, made it 
possible to test this hypothesis in C. elegans. The fact that RNA silencing in C. elegans can 
readily target and down-regulate genes required for RNA silencing makes the genes involved in 
RNA silencing ideal candidates for this test. The drh-1 gene will be of particular interest in this 
regard since drh-1 is known to play an essential role in RDVI but appears dispensable in RNA 
silencing targeting cellular transcripts.  
           DRH-1 as key component of RDVI appears to be unique to the nematode worm. Thus, 
function and mechanism study of DRH-1 may help unravel some unique features of worm RDVI. 
The fact that DRH-1 selectively mediates the silencing of invading viral RNAs suggests a 
hypothesis that DRH-1 is a RIG-I function analog that senses and mediates the silencing of 
invading viral RNAs. However, currently it remains possible that DRH-1 specifically mediates 
viRNA-guided silencing irrespective of the origin of silencing targets. To rule out this possibility, 
one will need to present both viral transcripts and homologous cellular transcripts to the same set 
of viRNAs to see whether DRH-1 selectively mediates the silencing of viral RNAs but not the 
cellular transcripts. Now, with the success in uncoupling the RDVI trigger and the RDVI target, 
we can have a straightforward test on this hypothesis by performing VIGS in drh-1 null mutants. 
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We reasoned that if DRH-1 selectively mediates virus silencing, VIGS should occur in a DRH-1-
independent manner. 
          In plants, RDVI features a systemic signal that is believed to prime an antiviral status prior 
to virus arrival (28). Two recent reports further suggested that the 21 nt siRNAs serve as the 
physical carrier of the systemic signal in plants (30, 31). Systemic antiviral silencing also occurs 
in insects although the mechanism involved differs (32). Previous studies have demonstrated that 
the systemic gene silencing can be triggered by artificial dsRNAs in C. elegans. Currently, it 
remains an open question whether RDVI also features a systemic antiviral signal in C. elegans 
which are known to share RdRP with plants. Although it is not appropriate to use our current 
VIGS setup to address this question, mainly due to the fact that the heat inducible promoter used 
to initiate FHV replication can be activated in most of somatic tissues, a modified version of our 
setup may help address this question. For example, if we produce the virus trigger and the gfp 
target in distinct tissues, we would be able to tell whether RDVI in C. elegans involves a 
systemic signal based on the status of the gfp silencing in response to viral replication.  
          In C. elegans, exactly how viral RNA targets are sliced by AGO-containing complexes 
remains largely unknown. The large number of C. elegans AGO proteins makes the dissection of 
the mechanisms involved even more challenging. The dilemma in studying the slicing 
mechanism of RDVI resides in the fact that the slicing of the viral targets can not be uncoupled 
from the dicing of the RDVI trigger and, as such, it is impossible to evaluate respective 
contributions to the destruction of invading viral RNAs. Apparently, our success in testing VIGS 
will facilitate the study on mechanisms involved in viral RNA slicing in that the dicing of the 
trigger and the slicing of the target are completely uncoupled in VIGS and, as such, the 
accumulation of the VIGS target is solely affected by the slicing mechanism. Moreover, since the 
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slicing of the VIGS target is mediated by both primary and secondary viRNAs (Figure 4.2 panel 
B&C), our study on the slicing mechanisms will be further facilitated by the fact that, in rrf-1 
knockouts, the slicing mediated by primary viRNAs can be further uncoupled from  the slicing 
by secondary viRNAs. C04F12.1 is another C. elegans AGO protein that contributes to RDVI 
and, like RDE-1, features the key catalytic residues of RNase H (62, 103). Currently, it remains 
unclear whether C04F12.1 recruits primary viRNAs for viral target cleavage.  Now, with the 
success in testing VIGS in C. elegans, this question can be easily addressed by assaying the 
efficiency of VIGS in double mutant corresponding to C04F12.1;rrf-1. 
          For currently unknown reason, irrespective of the worm genetic backgrounds, FHV RNA1 
and its derivatives replicate less efficiently in worm larvae compared to that in adult worms. As a 
result, the VIGS phenotypes observed in this report were less prominent in worms developed 
from heat induced larvae. This may have also prevented us from observing more pronounced 
VIGS phenotypes that take longer time to develop.  
         Orsay virus naturally infects C. elegans and exhibits enhanced replication only in mutant 
worms defective in RDVI or in the presence of a functional RNA silencing suppressor (50), 
indicating that the current Orsay virus isolate may be a natural mutant deficient in RNA silencing 
suppression. If proved true, this Orsay virus isolate together with its RNA2 based replicon may 
serve us well as an ideal VIGS trigger in C. elegans. As shown in this report, the RNA2 of FHV 
can be modified to function as a trigger of VIGS without compromising the viral replication. 
Very likely, the same strategy can be used for developing an Orsay virus RNA2 based replicon 
as the trigger of VIGS. The genomic RNA2 of Orsay virus contains two ORFs. One of the ORFs 
encodes the viral coat protein whereas the other encodes a putative protein, named delta protein, 
with unknown function (50). It is likely that one of the ORFs can be replaced with foreign 
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sequence for VIGS. It can be expected that an Orsay virus based trigger will allow for prolonged 
observations of VIGS phenotypes since Orsay virus infects worm larvae and, unlike FHV whose 
optimal replication temperature is above 25C, replicates efficiently at room temperature.  
7.3 RSD-2 and RDE-4-independent RDVI  in C. elegans 
         rsd-2 was first identified as a gene that enables RNAi spreading from soma to germline 
(64). A role of rsd-2 in RDVI was then revealed in a genetic screening that utilized RNAi 
mediated gene knockdown to phenocopy genetic mutants (62). Recently, a genetic study further 
suggested that rsd-2 helps maintain normal chromosomal function, such as transposon control, 
under unfavorable conditions (67). Currently, how rsd-2 contributes to those biological processes 
remains poorly understood. rsd-2 is unique to nematode worms, such as C. elegans which are 
known to encode single Dicer required for the biogenesis of both siRNAs and miRNAs. Thus, 
functional and mechanistic study of rsd-2 is expected to not only shed light on mechanism 
whereby rsd-2 helps maintain chromosomal integrity in response to environmental stresses but 
also reveal the unique aspects of RDVI in single-Dicer invertebrates. Here we show that rsd-2 
functions in two parallel genetic pathways that mediate antiviral silencing in rde-4-dependent 
and rde-4-independent manner respectively. In Arabidopsis, dsRNA binding protein regulates 
RDVI by facilitating the processing of viral dsRNA into siRNAs by one of the four Dicers (23, 
24).  In Drosophila, the RDE-4 homologue R2D2 contributes to the function of viRNAs 
produced by one of the two Drosophila Dicers (95, 96, 141). Therefore, by demonstrating the 
rde-4-independent mechanism for primary viRNA biogenesis, our study, suggested that RDVI in 
single-dicer invertebrates can be initiated in the absence of a dsRNA binding protein. 
     Previously, it has been shown that dsRNA of high concentration triggers RNAi in C. elegans 
in the absence of RDE-4 (71). This observation suggests that viruses, as powerful replicators that 
92 
 
rapidly produce large amount of dsRNA replication intermediates, may trigger RDVI in the 
absence of RDE-4. Here we show that, with an increase in viral replication level, primary 
viRNAs were detected at high level in rde-4 mutants containing either rsd-2 or rrf-1 null allele, 
suggesting an rde-4-independent mechanism for the generation of primary viRNAs (Figure 
5.2&5.4). Apparently such an increase in viral replication and viRNA accumulation can not be 
attributed to residual rde-4 function in the rde-4 allele used in this study since FR1gfp-derived 
siRNAs were not detected in rde-4 single or drh-1;rde-4 double mutants under the same 
condition (62) (Figure 5.1 panel E, Figure 5.2 panel A, Figure 5.4 panel C and Figure 5.5 panel 
B). Thus, by demonstrating the existence of an rde-4-independent pathway for antiviral silencing, 
we  explained why dsRNAs of high levels triggers RNAi in the absence of RDE-4 in C. elegans 
(71). Notably, although readily detectable in worms, such as rde-1, rrf-1 and rsd-2 mutants, that 
are defective in secondary viRNA biogenesis, virus-derived primary siRNAs were hardly 
detectable in wild type N2 worms or worms defective in rde-4 (Figure 5.1 panel E, 5.2 panel A, 
5.3 panel C&5.4 panel C ). This may simply reflect the fact that antiviral silencing in both rde-4-
dependent and rde-4-independent mechanisms is amplified by the secondary viRNAs and, as a 
result, much less viral dsRNAs will be processed into primary viRNAs by Dicer in the presence 
of secondary viRNAs.  
 Notably, our observations suggested that rde-1 also plays a role in rde-4-independent 
RDVI like rsd-2 does (Figure 5.5). Interestingly, an increase in FHV replication level was 
observed in rde-1;rsd-2 double mutants compared to rde-1 single mutants. Probably, rde-1 plays 
a major role in rde-4-dependent but a minor role in rde-4-independent RDVI and as a result, 
antiviral silencing in rde-1 mutants is further compromised in the presence of an rsd-2 null allele. 
Nevertheless, by analyzing the accumulation of viral transcripts and primary viRNAs in various 
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single and double worm mutants defective in RDVI in our study, for the first time, demonstrated 
that, in addition to the conventional rde-4-dependent pathway, there is an rde-4-independent 
pathway for antiviral silencing in C. elegans (Figure 5.7).  Previously, we have shown that 
another RDE-1-related worm AGO, termed C04F12.1, plays a role in RDVI. It would be 
interesting to test whether C04F12.1 plays a role in rde-4-independent RDVI. C. elegans is 
known to encode a large number of AGO proteins. Thus, testing the rde-4 dependence of 
C04F12.1 may allow us to address the question whether different worm AGO proteins 
specifically function in mechanistically distinct RDVI pathways in C. elegans.  
          rsd-2 is known to be required for the accumulation of secondary, but not primary, 
endogenous siRNAs (66). Currently, it remains unclear whether rsd-2 contributes to RDVI 
through similar mechanism. Here we show that FR1gfp-derived primary siRNAs accumulated in 
rsd-2 with a pattern similar to that in rrf-1 or rde-1 single mutants which are known to 
accumulate primary viRNAs (Figure 5.1 panel E, 5.2 panel A&5.3 panel C). This finding 
suggests that, similar to that in endogenous RNAi, rsd-2 enhances cell autonomous antiviral 
silencing by contributing to the accumulation of secondary, but not primary, viRNAs. This 
finding explained why rsd-2 mutants are resistant to low dosage but sensitive to high dosage of 
dsRNAs (66). Presumably, when the trigger dsRNAs are present at high concentration sufficient 
primary siRNAs will be produced to trigger efficient RNAi in the absence of secondary siRNAs. 
However, when the trigger dsRNAs are introduced at low level, efficient RNAi will require those 
dosage-sensitive RNAi factors, such as RSD-2, RDE-10 and RDE-11, which amplify RNAi by 
promoting the production/accumulation  of secondary siRNAs (66). Notably, the replication of 
both FHV and Orsay virus was further enhanced in rsd-2 mutants compared to that in rrf-1 
mutants, suggesting that rsd-2 may also contribute to the function of primary viRNAs. RSD-2 
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contains 3 tandem domains of unknown function at the N-terminus. Functional characterization 
of these domains may yield further insight into the mechanistic basis of RSD-2 in RDVI.   
          Like that in plants, RNAi in C. elegans involves an intercellular signal that is responsible 
for systemic spread of RNAi (1, 142, 143). A recent study further suggested that long dsRNAs or 
their processed intermediates may be the physical carrier of this intercellular signal (70). 
Consistent with this finding, systemic spreading of the intercellular signal requires the 
transmembrane protein SID-1 that transports dsRNAs without a size preference and thus may 
facilitate the intercellular transportation of the silencing signal (65, 68, 130). Previously, it has 
been shown that SID-1 is dispensable for RDVI triggered by artificial viruses, such as vesicular 
stomatitis virus and FHV (19, 105). Currently, whether SID-1 contributes to RDVI under natural 
conditions remains largely unknown. To address this question, we compared Orsay virus 
infection between wild type N2 worms and sid-1 mutants and found that Orsay virus infection 
was not further enhanced in the sid-1 mutants (Figure 5.6). Probably, worm RDVI involves an 
intercellular silencing signal that is transported through a SID-1-independent mechanism. 
Consistent with this hypothesis, SID-1 was shown to be dispensable  for the export of the mobile 
silencing signal in C. elegans (144). Alternatively, SID-1 as a key component of systemic RNAi 
may be active in non-intestine tissues and as a result, its role in systemic RDVI can not be 
identified using Orsay virus which mainly targets the intestine cells for replication (50). 
Moreover, probably due to the lack of an RDVI suppression activity, Orsay virus is known to be 
highly sensitive to RDVI (104). It is thus possible that the replication of Orsay virus in sid-1 
mutants is suppressed by intracellular antiviral silencing, making the intercellular antiviral 
silencing redundant in keeping this particular virus under control.  
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           Unlike RDE-4 which plays an important role in the biogenesis of endogenous siRNAs, 
DRH-1 appears to be a dedicated factor of worm RDVI (62, 94). DRH-2 shares significant 
sequence homology with DRH-1 but appears to negatively regulate worm RDVI (62). These 
observations together raised an interesting question whether DRH-2 specifically targets and 
regulates the function of DRH-1 thereby to negatively regulate the rde-4-dependent RDVI. 
Apparently, by addressing this question we will be able to find out whether worms have evolved 
such a mechanism that would allow for specific regulation of RDVI without affecting the normal 
cellular function under unfavorable environments.  
7.4 RIG-I-like RNA helicases and antiviral innate immunity  
         It is intriguing that, as an essential component of the nematode antiviral RNAi, DRH-1 
encodes the helicase and C-terminal domains homologous to mammalian RLHs, since RLHs 
initiate the IFN-dependent antiviral immunity that is absent in C. elegans (62). In this study, we 
developed an assay to dissect the domain requirement of DRH-1 in antiviral RNAi against both 
the FHV replicon and Orsay virus by transgenic expression of the wild type and mutant forms of 
DRH-1 in animals carrying a loss-of-function allele of drh-1. Our results show that the antiviral 
activity of DRH-1 requires its helicase domain and CTD as well as the worm-specific NTD. We 
also demonstrate that the homologous helicase and CTD domains encoded by either the worm 
DRH-2 or human RIG-I can functionally replace the corresponding domains of DRH-1 to 
mediate antiviral RNAi in C. elegans. Strikingly, three amino acid substitutions in the KWK 
motif predicted to prevent the physical interaction of RIG-I with viral dsRNA abolished the 
antiviral activity of the CTDs of both RIG-I and DRH-1 in C. elegans. These findings strongly 
suggest that antiviral RNAi in C. elegans requires an activity of DRH-1 to detect viral dsRNA 
known to be essential for the virus sensing by RIG-I.   
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     Available data illustrates an identical genetic requirement for antiviral RNAi triggered by 
either the replication of FHV or the infection of Orsay virus (8, 9, 19, 50, 62). This is probably 
because induction of nematode antiviral RNAi requires the recognition and processing (into 
siRNAs) of dsRNA produced during RNA virus replication and Orsay virus is closely related to 
FHV (50). Consistently, we found in this study that DRH-1 identified in a feeding RNAi screen 
based on the FHV replicon-induced antiviral RNAi is also necessary for the nematode defense 
against Orsay virus infection. Moreover, we show that antiviral RNAi induced by both the FHV 
replicon and Orsay virus requires DRH-3. We note that DRH-3 is known to participate in 
exogenous and endogenous RNAi of C. elegans (134, 136), in contrast to DRH-1 that is largely 
dispensable for RNAi targeting cellular transcripts whether or not the silencing siRNAs are 
processed from a replicating viral RNA or an exogenous long dsRNA. Using an improved 
protocol for Northern detection of small RNAs (105), we found that the 23-nt primary siRNAs 
targeting the FHV replicon reproducibly accumulated to higher levels in drh-3 mutants than in 
drh-1 mutants although both mutants supported similar replication levels of the replicon. Deep 
sequencing further indicated that the abundant viral siRNAs produced in drh-3 mutants did not 
include a population of secondary siRNAs. These observations together indicate that DRH-3 
regulates RNAi targeting both cellular transcripts and viruses by participating in the biogenesis 
of secondary siRNAs after Dicer-dependent production of primary siRNA biogenesis, as 
proposed previously for its role in endogenous RNAi (136). By contrast, DRH-1 may act to 
specifically enhance production of viral primary siRNAs by facilitating the recruitment of the 
heterodimer DCR-1/RDE-4 to the viral dsRNA bound by DRH-1 for the subsequent processing 
into primary siRNAs by DCR-1. Our model is consistent with a previous study that detected 
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physical interaction of RDE-4 with DRH-1, but not with DRH-3 (75), and would also explain 
why the function of DRH-1 is essential only for RNAi against virus infection.  
          Viral RNA replication occurs in discrete subcellular compartments such as the spherules 
on the outer membrane of mitochondria shown for FHV (145). Virus dsRNA replicative 
intermediates are also found in complexes with viral replicase and host co-factor proteins. These 
physical barriers may prevent DCR-1/RDE-4 complex from gaining access to viral dsRNA. 
DRH-1-mediated detection of the unique viral dsRNA for the production of primary siRNAs 
may be particularly important to ensure effective RNAi against the replicating viral RNAs in C. 
elegans, which encodes only one Dicer, unlike multi-Dicer plant and insect hosts that process 
distinct siRNA and miRNA precursors with dedicated Dicer proteins (81). However, production 
of primary siRNAs in the absence of DRH-1 may still be sufficient for RNAi to target the non-
replicating cellular transcripts.  
         Rapid progress has been made to understand the interferon-regulated effector mechanism 
of the mammalian antiviral immunity initiated by RIG-I, MDA5 and LGP2 in the cytosol  (146). 
Our study provides an interesting parallel for a three-member family of RLHs to regulate 
antiviral defense in C. elegans using RNAi as the effector mechanism. Analogous to the role of 
the N-terminal CARDs of RIG-I in the downstream immune signaling (146), the interaction of 
DRH-1 with RDE-4 may involve the worm-specific NTD of DRH-1, which is critical for the use 
of RNAi as the effector mechanism. Therefore, detection of viral dsRNA by related RLHs in 
nematodes and mammals activates unrelated effector mechanisms, illustrating functional 
diversification of RLHs during evolution via acquisition of specific N-terminal signaling 
domains. An alternative model is that the mammalian RLHs have a conserved activity to recruit 
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DCR-1 for the production of viral siRNAs to activate antiviral immunity by an RNAi effector 
mechanism.  
7.5 Finale 
Virus-host interaction represents one of the most intimate pathogen-host interactions in 
that viruses are intracellular parasites that obligate rely on host for reproduction. To suppress 
viral infection, cellular organisms have evolved a wide spectrum of cytosolic antiviral 
mechanisms. RNAi is such an antiviral mechanism that has shaped many aspects of virus-host 
interaction, including virus clearance and viral pathogenesis. To date, exactly how antiviral 
RNAi protect single-Dicer organisms from virus attack remains largely unknown. My study 
described in this thesis represents the very first attempt that aims to address this question. 
Findings from my study suggest that 23-nt siRNAs play a major role in antiviral silencing and 
host gene silencing in the single-dicer organism C. elegans. It was also clear from my study that 
some worm-specific genes allow for antiviral RNAi to be initiated in the absence of dsRNA 
binding proteins, which is in sharp contrast to that in plants and insects which are known to 
produce more than one Dicer protein. My study further suggests that RIG-I-like RNA helicases 
as virus sensors are conserved in mechanistically unrelated antiviral immune responses. Thus, 
my research efforts not only revealed some unique features of antiviral RNAi in single-dicer 
organisms but also developed C. elegans as a powerful animal model for the study of many 
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